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Chapter 1
Introduction
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‘The chains of habits are too weak to be felt until they are too strong to be 
broken’  -Dr.Samuel Jones
The growth and development of civilisation and industrialisation subjected Human 
beings to varied amount of stress and tension. Most of them adapt psycho-stimulat-
ing and euphoria-inducing habits such as smoking, alcoholism, areca nut chewing 
etc. as stress relieving methods. These habits are highly addictive and affect human 
body with many crippling mental and physical disorders. Oral Submucous fibrosis 
(OSMF) is one of the devastating conditions resulting from these tension relieving 
habits.
OSMF is a chronic, debilitating condition of the oral cavity causing progressive scar-
ring of the oral mucosa.1 In ancient Indian medicine Shushrutha described a condi-
tion which he named it as “Vidari” presenting symptoms of progressive narrowing of 
the mouth, depigmentation of oral mucosa and pain on taking food. These features 
precisely fit in with symptomatology of OSMF.2 
Schwartz J (1952)3 described a fibrosing condition of the oral cavity in five female 
Indian immigrants to Kenya and termed it as “Atrophica Idiopathica (Tropica) Muco-
sae Oris”. (Schwartz J. Atrophia idiopathica (tropica) mucosae oris.Presented at the 
Eleventh International Dental Congress, London, 1952) 
Joshi SG4 (1953) and Lal D5 (1953) were the first Indian workers to describe this 
condition and termed it as “Sub Mucous Fibrosis of Palate & Pillars” and “Diffuse 
Oral Submucous Fibrosis” respectively. 
Other names suggested in literature include: 
   Idiopathic scleroderma of mouth6 
   Submucous fibrosis of the palate7 
   Submucous fibrosis of palate and cheek8 
   Idiopathic palatal fibrosis9 
   Oral submucous fibrosis10 
However, the most accepted term is “Oral Submucous Fibrosis” which was suggest-
ed by Pindborg JJ & Sirsat SM (1966)10 describing the nature of the condition in a 
simplified form. They defined the condition on the basis of clinical and histopathologi-
cal findings as- “an insidious chronic disease affecting any part of the oral cavity and 
sometimes the pharynx. Although occasionally preceded by and /or associated with 
vesicle formation, it is always associated with a juxtaepithelial inflammatory reaction 
followed by a fibro elastic change of the lamina propria with epithelial atrophy leading 
to stiffness of the oral mucosa and causing trismus and inability to eat”.10 
Buccal mucosa is the commonest site followed by labial mucosa, retromolar pads, 
soft palate and floor of the mouth. Rarely fibrotic changes of the pharynx, esophagus 
and paratubal muscles of eustachian tubes have also been observed.11 Initially OSMF 
presents with burning sensation, hypersalivation/xerostomia and mucosal blanching 
with marble like appearance.1 Later on, the mucosa becomes leathery and inelastic 
with palpable fibrous bands resulting in restricted mouth opening. Eventually, OSMF 
leads to difficulty in swallowing, speech & hearing defects and defective gustatory 
sensation.11 Paymaster in 1956 described the development of a slow-growing squa-
mous cell carcinoma in one third of OSMF cases seen in the Tata Memorial Hos-
pital, Bombay12 and postulated it as a precancerous condition.12,13 Later studies by 
Pindborg substantiated this report.14-16 The WHO definition for an oral precancerous 
condition - “a generalized pathological state of the oral mucosa associated with a 
significantly increased risk of cancer,” accords well with the characteristics of OSF.12 
The precancerous potential was also emphasized by other authors,17-21  based on 
clinical and epidemiological grounds.12 What makes it more sinister is the malignant 
transformation rate, which has been reported to be around 7.6% over a 17-year pe-
riod.18,22,23 Perhaps what is most distressing about the condition is most of the time 
difficult to diagnose is clinically owing to its malignant transformation associated with 
severe trismus.1 Surveys in various cancer hospitals in India reveal a 15-20% fre-
quency of oral cancer among all cancers.24 The finding of a high frequency of OSMF 
among oral cancer patients in India (e.g., 40 among 100 oral cancer patients) has 
strengthened the postulated link between the two.12 Until recently, it was thought to 
be localized to the Indian subcontinent, China and other regions of South East Asia 
but is now considered to be of global importance due to large numbers of migrant 
populations also demonstrating the condition.1
In the 1960s the prevalence figures observed in 35,000 Indians visiting dental col-
leges were - Lucknow 0.5%, Bombay 0.7%, Bangalore 0.2% and Trivandrum 1.2%.25 
In 1968, a survey was conducted among 50,915 villagers to know the prevalence 
of OSMF in rural India and the prevalence figures were-Gujarat 0.2%, Kerala 0.4%, 
Andhra Pradesh 0.04%, Singhbum 0% and Darbhanga 0.7%.26 In Maharashtra, 
the prevalence is 0.3% among 101,761 villagers.27 In Ernakulam district of Kerala, 
the yearly incidence for males and females combined was 13 per 100,000 person-
years.12
In 1992, the prevalence of OSMF in Trivandrum and Quilon were found to be 0.32% 
and 0.27% respectively.11,28 The prevalence of OSMF has increased over the past 
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four decades from 0.03% to 6.42%.11, 26,29 In the Indian population in South Africa, the 
prevalence of OSMF was between 0.5%-1.2%.27 In 2002, the statistics of OSMF for 
India alone was 5 million people.30 The disease has also been reported among local 
population in Sri Lanka, Myanmar, Singapore, Thailand, China, South Vietnam, Fiji, 
Papua New Guinea, and Saudi Arabia and sporadically among Europeans.31 In 2011 
survey, OSMF amounted to almost 4.38% in the span of 16 years in an Indian teach-
ing hospital alone. It was also observed areca nut/betel nut was associated with 
almost 78% of the patients with OSMF, while smoking alone leading to OSMF was 
seen in a very small percentage of patients (2.43%) and was especially associated 
with beedi smoking. Multiple habits, i.e., areca nut, smoking, alcohol was observed 
in 6.82% people.23 The prevalence of OSMF in a recent north Indian survey by Ni-
gam et al. (2013) was 6.3% (63/1000). It was also found that gutkha chewing was 
the most common abusive habit (42/63) amongst OSMF patients. The prevalence 
found was more in urban patients and severity of disease was more in rural popula-
tion.11 
OSMF occurs over a wide age range. The youngest to be reported was a 4 year old In-
dian immigrant in Canada31 and the oldest patient more than 80 years. However, major-
ity of the patients diagnosed with OSMF are between the age 20-40 years.10,22,32 OSMF 
is thought to have a female preponderance.10,33,34 However, the reports of sex ratio vary. 
In a report of the prevalence of OSMF among 50,915 Indian villagers, the female: male 
ratio was 3:1.13 In Ernakulam, the yearly incidence was reported to be 9 for males and 
20 for females per 100,000 person years.35 A study by Ranganathan et al.36 had revealed 
male predisposition 9.9:1. There was a high male predilection, almost to the ratio of 11:1 
in a recent study22 which is in accordance with others studies.11 The higher involvement 
of males in all studies, reflects their easy access to the abusive habits when compared 
with females.11 
Over the years, many theories linking oral submucous fibrosis to various risk factors 
have been proposed. The Indian habit of repeatedly insulting the oral mucosa with 
very spicy, pungent foods and irritant like supari (areca nut), pan (betel leaves), to-
bacco (chewed & smoked) over a period of years have all been incriminated by vari-
ous authors as causative agents.22 Systemic factors like nutritional deficiency, genet-
ic predisposition and autoimmunity were also proposed in pathogenesis of OSMF.1,22 
However the precise aetiology of OSMF is still unknown.1 Till date no conclusive 
evidence has been found despite many extensive investigations on factors impli-
cated.1,22 Most of the ideas proposed have been derived from existing clinical and 
epidemiological data.12
Areca nut chewing is strongly correlated with OSMF. This observation was made af-
ter it was seen that OSMF did not occur in populations who did not chew area nut. In 
South Africa it was observed that OSMF was more common among Indians and not 
seen among Blacks as areca nut chewing is more common among the Indian popula-
tion there.26,37 A high correlations has been found in Taiwan between areca nut chewing 
and oral submucous fibrosis.35 In an Indian study with 275 cases there was increase of 
OSMF was seen in 5 year period. The trend corresponded to an increase in areca nut 
(mawa) chewing habit in that area.23
In vitro studies have shown that arecoline and arecaidine content of aracanut stimu-
late proliferation of fibroblasts and enhance the synthesis of collagen.38,39 However 
in an experimental set up, 2% arecoline was applied to the palatal surfaces of Wistar 
rats. Only two rats showed a staining pattern similar to that seen in classic human 
submucous fibrosis of the palate. The investigators concluded that arecoline prob-
ably did not play a role in causation of OSMF.40
The high concentration of copper in areca-nut also has been found to stimulate lysyl 
oxidase activity, an enzyme essential to the final cross-linking of collagen fibres.1 
Increased copper has been seen in mucosa affected by OSMF, which supports its 
role in fibrogenesis by enhancing lysyl oxidase activity.1
The pathogenesis of the disease is not well-established, but the cause of OSMF is 
believed to be multifactorial. Various mechanisms were suggested for the etiopatho-
genesis of OSMF41,42, including: 1) clonal selection of fibroblasts with a high amount 
of collagen production during long-term exposure to areca nut ingredients43 2) stabi-
lization of collagen structure by catechin and tannins from betel quid decreases the 
secretion of collagenase44 3) production of stable collagen (type I trimer) by OSMF 
fibroblasts45 4) increase in collagen cross-linking by up-regulation of lysyl oxidase46 
5) deficiency in collagen phagocytosis and effect of fibrogenic cytokines secreted by 
activated macrophages and T lymphocytes47,48 and 6) deficiencies in micronutrients 
and vitamins.41,42
The incidence of OSMF is on the rise in the younger age group in India. OSMF is 
silently spreading like wildfire throughout in India, as pan masala and gutkha are 
easily available in most part of the country even to young children at a very low 
price.1,50 We are observing a big epidemic of OSMF across India and are afraid that 
we will witness an epidemic of cancer in near future. But unfortunately, the complex 
pathophysiology of this condition is still obscure and there are no reliable diagnostic 
parameters, which can indicate the irreversible nature and/ or chance of malignant 
transformation.1, 50 Also to date, there is no method which can be seen as the defini-
tive treatment for oral submucous fibrosis. 
 “Behind a restricted mouth lies a restricted personality.” This is more or less true 
for the patients suffering from OSMF, a highly perplexing disease. Unfortunately the 
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condition is seen mostly in developing countries and is failed to get attentions from 
international health organisation owing to its remoteness.49 Eventually we see more 
number of patients every year due to lack of awareness and treatment. Hence the 
condition demands more understanding of pathogenesis and its predisposing fac-
tors to develop prevention modalities. In this context, we consider systemic predis-
position and pre-conditioning of the oral mucosa is a promoting factor responsible 
for development of OSMF. 
In the present prospective case control study, an attempt has been made to know the 
association between water copper ion concentration and pathogenesis of OSMF. In 
chapter 2 we will review and discuss all general components of OSMF, including the 
terminology, presentation, aetiology, and pathogenesis, and provide a brief overview of 
its management. In chapter 3 we postulate the novel biological pathway through which 
copper is thought to predispose oral mucosa to OSMF. The hypothesis explains various 
unexplored aspects of the disease.  Chapter 4 include pilot investigation on 50 patients 
with clinically and histologically diagnosed OSMF.  The preliminary study investigates 
the role of copper in drinking water in the pathogenesis of OSMF.  In chapter 5 the 
association of drinking water copper and OSMF will be further investigated in a hetero-
geneous population in Hyderabad-Karnataka, India.  The study will evaluate 3 groups, 
each of 100 patients: those with OSMF who chewed gutkha, those who chewed gutkha 
but did not have OSMF and healthy controls who did not chew gutkha. In chapter 6 we 
will investigate association of pattern of saliva pooling and distribution of OSMF in an 
attempt to postulate a possible mechanism for the sporadic incidence of the OSMF. In 
chapter 7 we will discuss about all studies with their impact, emerging challenge and 
preventive measures. 
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Abstract
Oral submucous fibrosis (OSMF) is a complex, debilitating, and precancerous condi-
tion. Formerly confined to the Indian subcontinent, it is now often seen in the Asian 
populations of the United Kingdom, USA, and other developed countries, and is 
therefore a serious problem for global health. The well-known causative agent of the 
disease, areca-nut is now recognised as a group one carcinogen. We review and 
discuss all components of OSMF, including the terminology, presentation, aetiology, 
and pathogenesis, and provide a brief overview of its management.
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Introduction
Oral submucous fibrosis (OSMF) is a chronic, debilitating disease characterised by 
juxtaepithelial fibrosis of the oral cavity. It is regarded as a precancerous and poten-
tially malignant condition.1,2  The most widely accepted definition of the disease by 
Pindborg and Sirsat3 is one of an insidious, chronic disease that affects any part of 
the oral cavity and sometimes the pharynx. Although occasionally preceded by, or 
associated with, formation of vesicles, it is always associated with a juxtaepithelial 
inflammatory reaction followed by fibroelastic change of the lamina propria and epi-
thelial atrophy that leads to stiffness of the oral mucosa and causes trismus and an 
inability to eat.3
The definition by the World Health Organization (WHO) of an precancerous oral 
condition: “a generalized pathological state of the oral mucosa associated with a 
significantly increased risk of cancer” fits well with the characteristics of OSMF.4,5 
The condition is thought to be multifactorial in origin with a high incidence in people 
who chew areca-nut,6 and a significant malignant transformation rate (7–30%)7 pos-
es global problems for public health. The physical effects, which include a burning 
sensation in the mucosa and progressive trismus, can also have psychological and 
social implications for patients.
Terminology
In 1952, Schwartz described a condition in 5 Indian women that he called “atrophia 
idiopathies (tropica) mucosae oris” (Schwartz J. Atrophia idiopathica (tropica) muco-
sae oris. Presented at the Eleventh International Dental Congress, London, 1952); 
Joshi coined the term “submucous fibrosis of the palate and pillars”.8 Other names 
suggested include “diffuse oral submucous fibrosis”, “idiopathic scleroderma of the 
mouth”, “idiopathic palatal fibrosis”, and “sclerosing stomatitis”.3,4 Pindborg and Sir-
sat used the term “submucous fibrosis” although they suggested that a more appro-
priate name would be “juxtaepithelial fibrosis”.3 Its premalignant nature was first de-
scribed by Paymaster in 1956.9
Clinical presentation
Clinical presentation depends on the stage of the disease.10 Initially, most patients 
present with a burning sensation or intolerance to spicy food, and they may have 
vesicles, particularly on the palate. Ulceration and dryness of the mouth is later fol-
lowed by fibrosis of the oral mucosa, which leads to rigidity of the lips, tongue, and 
palate, and trismus.10
Petechiae, in the absence of blood dyscrasias or systemic disorders, are found in 
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about 22% of patients with OSMF, and occur most often on the tongue followed by 
the labial and buccal mucosa.4,11
A useful clinical sign is pain on palpation in the sites where submucosal fibrotic 
bands are developing, 11 and trismus is caused mostly by fibrosis in the dense tissue 
around the pterygomandibular raphae.11 Fibrosis of the eustachian tube may lead to 
deafness.7, 12  When the fibrosis involves the nasopharynx or oesophagus, patients 
may experience referred pain to the ear, a nasal voice, and dysphagia to solids; usu-
ally these are features of more advanced disease.7,11
Fig. 1. Clinical appearance of oral mucosa in oral submucous fibrosis (A–C) and malignant 
changes in the condition (marked with arrows in D).
The most obvious clinical signs include blanched, opaque oral mucosa with palpable 
fibrous bands (Fig. 1).10,13,14 Furthermore, the overlying epithelium may become dys-
plastic and malignant. Restricted mouth opening interferes with examination of the 
oral mucosa, and makes early diagnosis of cancer a daunting task.10,15-17
Epidemiology
Geographically, OSMF has a specific distribution and affects predominantly Asians 
(and particularly Indians) from the southern states, and Taiwanese.10,18 Other series 
of OSMF in Europe, the Far East, and the Pacific Rim have been reported.7,10,18 An 
estimate from 1996 indicated that globally, about 2.5 million people have OSMF,7 but 
studies have found that over 5 million people are affected in India alone (0.5% of the 
Indian population).1,7 ,19 It is also estimated that up to 20% of the world’s population 
use betel nut in some form, so the incidence of OSMF is likely to be much higher 
than current estimates suggest, and it is regarded as a public health issue in the In-
dian subcontinent, the UK,1,20 and South Africa.1,7,21 It is predominantly seen in the 
second or third decade, and recent data suggest a male predominance; however, 
both sexes are equally at risk.10,18 Oral cancer that arises in those who chew betel 
quid is one of the most common malignancies in south and southeast Asian coun-
tries,1,22 and with immigration from the Indian subcontinent to the UK, USA, and 
South Africa, oral and maxillofacial surgeons in these countries are likely to encoun-
ter the disease more often in future.7
Aetiology
At first, OSMF was thought to be idiopathic, but it was later concluded to be multifac-
torial in origin, and possible aetiological factors include capsaicin in chillies, iron, 
zinc, and deficiencies in essential vitamins.6,18,23,24 Various autoantibodies and spe-
cific human leucocyte antigens (HLA) in some patients have indicated an autoim-
mune role as well as a genetic predisposition for the disease.25 However, various 
epidemiological studies, large cross-sectional surveys, case–control studies, and 
cohort and intervention studies have provided overwhelming evidence that areca-nut 
is the main aetiological factor in OSMF.21,25-34 The nut is the endosperm of the fruit of the 
Areca catechu palm tree.7 A range of case–control studies have given convincing evi-
dence that there is a definite dose-dependent relation between areca-nut and causation 
of the disease, and it is well known that the onset of the disease is directly proportional 
to the concentration, incidence, and duration of chewing the nut (without tobacco).25,29,32,34 
Generally, younger patients develop clinical features of OSMF within 3.5 years from 
onset of the habit while in older patients it takes 6.5 years.25,27
Currently, in India, Pakistan, and Bangladesh, betel quid and gutkha are the most 
commonly used commercially freeze-dried areca-nut products. Gutkha (also spelled 
gutka or guthka, thought to be derived from Hindi meaning “a shred or small piece”) 
is a light brown, grainy powder available in compact storable sachets (Fig. 2). It con-
sists mainly of areca-nut, tobacco, and flavours, and is typically taken to relieve 
stress. When chewed it dissolves quickly in saliva and provides central stimulation, 
which is said to be more intense than tobacco.
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Fig. 2.  Picture showing betel leaf (A), a typical betel quid (B), contents of a tobacco betel 
quid with areca-nut (C), compact sachets of gutkha (D) and contents (E). Note the increased 
load of areca-nut compared with betel quid
Gutkha has replaced most of the commercial areca-nut preparations, and contains 
the nut in high concentrations along with tobacco. Betel quid commonly contains 
areca-nut (incorrectly known as betel nut), slaked lime, and A. catechu with or with-
out tobacco, and is typically wrapped in betel leaf (from the Piper betle, a pepper 
shrub).7 Although it is still often chewed (usually after meals and thought also to be 
an appetiser) in India, its consumption as an addictive habit has reduced. However, 
consumption of the addictive gutkha is increasing rapidly and its increased popular-
ity may be because it is easily accessible, and because of effective changes in price 
and marketing strategies.
Unlike pan masala, which has to be freshly prepared before use, gutkha is available 
in compact sachets, which are easy to handle, and allow it to be consumed at any 
point during the day. The habit often starts among young people, usually as a fashion 
or status symbol, because of peer pressure, or to imitate parents. It is often used by 
adults (such as taxi drivers or merchants) to cope with irregular meals, to relieve 
stress, or to stay awake during shift work, and even to relieve toothache.35 It is more 
highly addictive than ordinary chewing tobacco and is exported to well over 22 coun-
tries.35
Gutkha is usually placed into the buccal or labial vestibule (and sometimes beneath 
the tongue), and is chewed for up to an hour until the nut softens and dissolves com-
pletely in saliva. The excess is either spat out or swallowed. It is typically done sev-
eral times and more in those who are addicted. Many patients place it in the buccal 
vestibule at night while they sleep.
Pathogenesis
OSMF is essentially a disease of collagen metabolism,7 but despite research span-
ning more than 3 decades, its pathogenesis is still not fully understood. There is 
compelling evidence that the areca-nut has a primary role in the development of 
OSMF (Fig. 3), but it has yet to be elucidated.10,25 However, it seems that changes 
that occur in the extracellular matrix are likely to have a key role.25 These studies 
have focused on increased synthesis, or reduced degradation, of collagen, as pos-
sible mechanisms in the development of the disease25; there are changes in the 
normal collagen metabolism at different stages.
Areca-nut contains alkaloids, flavonoids, and copper, which all interfere with homeo-
stasis of the extracellular matrix. Four alkaloids – arecoline (most potent), arecai-
dine, guvacine, and guvacoline – are known to stimulate fibroblasts to produce col-
lagen.25 Flavonoids (tannins and catechins) inhibit collagenase, stabilise the collagen 
fibrils, and render them resistant to degradation by collagenase.10,25
The localised mucosal inflammation caused by areca-nut or gutkha results in the 
recruitment of activated T-cells and macrophages that lead to an increase in cyto-
kines and tumour growth factor beta (TGF-β).7 The latter considerably increases the 
production of collagen by activating procollagen genes, and upregulating procolla-
gen proteinase enzymes and lysyl oxidase activity.7,36
Simultaneously, TGF-β inhibits collagen degradation by activating the tissue inhibitor 
of matrix metalloproteinase (TIMP) genes and plasminogen activator inhibitor (PAI).7 
The high concentration of copper in areca-nut has been found to stimulate lysyl oxi-
dase activity, an enzyme essential to the final cross-linking of collagen fibres.1,7 In-
creased copper has been seen in mucosa affected by OSMF, which supports its role 
in fibrogenesis by enhancing lysyl oxidase activity.10,37- 40
Continually chewing areca-nut leads to increased activity of the masticatory mus-
cles, depletion of glycogen, and muscle fatigue. The reduced blood supply following 
fibrosis further promotes muscle fatigue and causes extensive degeneration and fi-
brosis in the muscles.41
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As previously mentioned, another two possible overlapping mechanisms are autoim-
mune factors and genetic predisposition.10  This has been substantiated by the pres-
ence of circulating immune complexes, immunoglobulins, and autoantibodies in 
some patients with OSMF, as well as altered cellular and humoral responses.10,25,42- 47 
Genetic susceptibility is supported by raised HLA-A10, -B7, and DR3 in OSMF pa-
tients compared with normal controls.11 The familial occurrence of the disease has 
been reported from India and South Africa.10,25,48- 51
It seems likely that OSMF is a multifactorial disease with initiators, promoters, and other 
modifying cofactors. But the tenet – loss of equilibrium of extracellular matrix and con-
tinuous deposition of extracellular matrix – in OSMF is currently well accepted.10
Classification schemes for OSMF
Several classification and staging systems based on different aspects of the disease 
have been suggested.52 The earliest classification by Pindborg and Sirsat3 in 1966 
was based on histopathological features and was updated in 2005 by Utsunomiya et 
al.36 The main disadvantage of them is the absence of any description of the epithe-
lial component of the disease.52 Wahi et al.53 presented the first clinical classification 
(of 3 groups) based on symptoms, and several others have now been pro-
posed.11,12,54-60 However, one well known and respected staging system (Khanna and 
Andrade41) has successfully combined histopathological and clinical features of the 
disease, and was developed mainly to aid in surgical management.
Malignant transformation and molecular markers
OSMF has a malignant transformation rate of 7–30% (Fig. 1D).7,12 Pathogenesis is 
thought to be multifactorial. The carcinogenic effects of tobacco acting in synergy with 
areca-nut is well known, but the second report on betel quid by the International Agency 
for Research on Cancer (IARC) identified areca-nut as a “group one carcinogen”.10,61,62 
Its genotoxic and mutagenic effects are attributed to polyphenols, alkaloids, and areca-
nut-specific nitrosamines such as N-nitrosoguvacoline, N-nitrosoguvacine, 3-(N-nitroso-
methylamino)propionaldehyde, and 3-(N-nitrosomethylamino)propionitrile.10, 57 Various 
studies have been conducted in an attempt to identify molecular markers that could be 
used to predict malignant change in OSMF. Recently, a loss of heterozygosity in 23 
“hotspot” loci which alter genes that control the cell cycle has been recognised as an 
important molecular marker for malignancy in OSMF.10, 63
Overview of management principles for OSMF
Patients with OSMF characteristically complain of two problems: an inability to open 
the mouth, which impedes function, and a burning sensation and intolerance to spicy Fig. 3.  Role of areca-nut in the pathogenesis of oral submucous fibrosis.
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foods (intolerance to normal diet in severe cases). Management aims to reverse or 
alleviate these signs and symptoms, stop the disease progressing, and minimise the 
risk of malignant transformation.64
The current protocol for the management of OSMF can be divided into 3 broad 
groups: surgical, physical, and medical treatments (Table 1). Surgical treatment, 
used mainly to manage trismus, involves incising and releasing the fibrotic areas, 
and leads to further scarring and fibrosis. The introduction of remote tissue (pedi-
cled, such as a buccal fat pad,65 nasolabial or platysmal flaps,66 or free tissue trans-
fer) in an attempt to release fibrosis67,68 is one approach but results are variable.
Physical treatment attempts to influence the remodelling of tissue by using move-
ment – for example, exercises and physiotherapy,58, 69 various splints or other devic-
es to improve mouth opening,70,71 ,72 or localised heat (such as with microwave dia-
thermy56,73,74). Medical treatment includes dietary supplements (vitamins, 
antioxidants), the use of anti-inflammatory drugs (principally corticosteroids), proteo-
lytic agents (such as hyaluronidase), anticytokines, and other agents that are not 
available in the UK. They can be given orally, topically, or by submucosal injec-
tion.58,64,75-90
Operation is generally reserved for established cases of OSMF while physical treat-
ment is usually combined with all other interventions. However, Kerr et al.64 recently 
hypothesised that cessation of the habit alone may have a considerable effect – 
more on the symptoms of OSMF than on reversing fibrosis.
Conclusion
As management of OSMF aims to slow the progression of the disease, better legis-
lation to govern the availability and sale of areca-nut is recommended, although im-
plementation of this may not be practical at present.10
Funding:  BAOMS Endowment grant for OSMF research awarded to G. Arakeri.
Surgical therapy Conservative therapy
Rationale: incision (incorrectly termed as 
excision) or surgical release of fibrous 
bands followed by forceful opening of the 
mouth (widening of the incised tissue or 
region), and covering of surgical defects 
using various flaps or synthetic biological 
material
Physical therapy
Physical exercise regimen
Splints or other mouth opening 
devices
Microwave diathermy
Extraoral flaps Medical therapy
Split thickness skin graft Modulators of inflammation:
Superficial temporal fascia pedicled flap Steroids
Temporalis pedicled flap Interferon gamma
Nasolabial flap Placental extracts
Amnion graft Immunised milk
Platysma myocutaneous muscle flap Modulators of vascularity or relief 
of ischaemia:
Intraoral flaps Pentoxiphylline
Tongue flap Buflomedil hydrochloride
Palatal island flap Nylidrin
Buccal fat pad Nutritional support and to combat 
reactive oxygen species:
Microvascular free flaps Beta-carotene
Radial forearm free flap Lycopene
Anterolateral thigh flap Vitamins
Alloplasts Micronutrients
Collagen membrane Fibrinolysis:
Artificial dermis Collagenase
Hyaluronidase
Chymotrypsin
Ayurvedic treatment:
Turmeric (Curcuma longa L.)
Tea pigments
Oxitard
Table 1: Management of oral submucous fibrosis.
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Abstract
Oral submucous fibrosis (OSMF) is known devastating disorder commonly seen in 
South Asian developing countries. It is directly linked to areca nut chewing and the 
contents of areca are subjected to multitude of investigations. Among all the con-
tents of areca nut, the copper element has been extensively studied. Most of the 
published studies have validated its association with OSMF because of its local ac-
tion. In this paper we postulate a novel biological pathway through which copper is 
thought to predispose oral mucosa to OSMF. The hypothesis is instructive in explain-
ing various unexplored aspects of the disease.
Introduction
Oral submucous fibrosis (OSMF) is a chronic debilitating and a premalignant condi-
tion affecting the oral cavity, pharynx, and upper digestive tract of the oral cavity. The 
characteristic pathophysiology of the disease is submucosal fibrosis characterized 
by juxta-epithelial inflammatory reaction followed by chronic change in the fibro-
elasticity of the lamina propria and associated with epithelial atrophy.1-6
OSMF’s morbidity/mortality is associated with limitation of mouth opening (trismus) 
which leads to significant masticatory dysfunction and discomfort.7 Once, the dis-
ease has developed, there is neither regression nor any effective treatment. It is 
considered as a pre-malignant stage of oral cancer and reported risk of malignant 
transformation is up to 7.6% over a 17-year period.2,8,9
The etiology of OSMF is unknown. The various hypotheses proposed suggest a multi-
factorial origin for this condition.10 Many studies have implicated various environmental 
factors as likely etiological factors. These include capsaicin in chillies, micronutrient defi-
ciencies, immunological, and genetic predisposition.3,1,11  There is also clinical and ex-
perimental evidence of presence of circulating immune complexes, immunoglobulin 
contents, and circulating auto-antibodies associated with specific HLA antigens in pa-
tient’s sera and alteration in cellular and humoral responses suggesting an autoimmune 
etiology and genetic propensity.1,13-19  However, the existing scientific literature at present 
makes it apparent that areca (betel) nut is the major etiological factor.1,20,21
While a clear association exists between areca chewing and OSMF, the precise 
mechanism still remains elusive and controversial.1 There has been a recent interest 
in the role of copper content of areca nut as a possible etiological factor in the devel-
opment of this disorder. The association between copper and OSMF has been linked 
on the basis that excess copper is found in the tissue of other fibrotic disorders such 
Wilson’s disease, Indian childhood cirrhosis and primary biliary cirrhosis (PBC).13,22 
However, the nature and characteristics of copper in this diseases is not been de-
fined clearly.10,22 Though the solubility of certain copper complexes in saliva has not 
fully evaluated, preliminary investigations have found that increasing copper is found 
in saliva during chewing of areca products. 10,22 
Copper in pathogenesis of OSMF
Areca nut has a high copper content (302 nmol/g), a substantial amount of which is 
released into saliva while chewing.23,24 The role of copper in the pathogenesis of 
OSMF is not clearly understood although it is known that the copper dependent en-
zyme, lysyl oxidase, secreted by the fibroblasts, facilitates the cross-linking of colla-
gen, thereby inhibiting its degradation.23 
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The possible role of copper as a mediator of fibrosis is supported by the demonstra-
tion of up regulation of lysyl oxidase in OSMF biopsies and in OSMF fibroblasts 
compared to normal fibroblasts from oral mucosa grown in culture. Copper added at 
various concentrations in vitro has also been shown to increase proliferation of fibro-
blasts in culture. The fibroblasts also followed specific growth characteristics of cell 
doubling time of 3.2 days for OSF and 3.6 days for normal fibroblasts.13,25-27
The nature and characteristics of copper compounds in the areca is as yet unknown, 
though there is evidence to suggest that the metal–matrix binding of copper in plants is 
associated with lectins and glycoproteins. The solubility of these complexes in physiolog-
ical fluids as saliva has not been fully evaluated either, but studies have shown that sol-
uble copper is extracted into saliva following chewing areca products.10,27
Several factors may influence the bioavailability and subsequent absorption of cop-
per by the oral mucosa. These factors include binding to non-soluble complexes, 
such as hemicellulose, dietary carbohydrates, dietary fats, the presence of amino 
acids, other mineral elements and the pH of the oral environment .27,28 This would 
suggest that the composition of the quid or pan masala may have a significant effect 
on the availability of copper in the oral cavity. The mechanisms that regulate the 
uptake of copper by cells of the oral mucosa are also not fully understood. At a cel-
lular level, there is evidence to support the role of membrane-bound copper trans-
porting adenosine triphosphates (Cu-ATPase) in the uptake of copper by cells.
The exact mechanism for this is unclear, but probably the copper binding sites form 
an extended polypeptide chain at the N-terminus of the trans-membrane domain. 
Recently in vitro kinetic studies using human skin fibroblasts have demonstrated that 
fibroblasts possess an effective system for the uptake of copper from the culture 
medium.27,29 Intracellular copper may possibly form tissue complexes that then fa-
cilitate the upregulation of collagen synthesis and subsequent cross-linking via the 
lysyl oxidase pathway.27
Copper may also bind to p53 protein causing aberrations in the oral keratinocytes.10,22 
Studies have also found an increased concentration of copper in fibrotic tissue in 
unilateral OSMF patients. Thus it was postulated that the site on which patient ha-
bitually kept the quid had increased the copper levels suggesting the local action of 
copper on oral mucosa.22,30
The hypothesis
Various hypotheses put forward to date have not been proven conclusively and the 
precise mechanism of copper mediated pathogenesis of fibrosis still remains elu-
sive. Most studies on OSMF have emphasized only on the oral copper availability 
and its local mucosal action. An equally important second aspect which needs to be 
considered is the pre-conditioning of the oral mucosa by a prolonged, chronic copper 
exposure. Considering the results of existing studies questions can be asked as to 
why there is often disease progression even after the cessation of the areca chewing 
habit, and why there is recurrence even after medical therapy in absence of areca 
chewing.
We postulate that the chronic exposure to subtle high normal copper diet (food, cop-
per potable water) predisposes the oral mucosa to OSMF. This may be considered 
through two overlapping pathways, namely alteration of normal salivary copper con-
centrations by increased secretion and secondly preconditioning of the oral mucosa 
through chronic exposure to salivary copper. When the preconditioned oral mucosa 
and saliva faces a copper challenge during areca nut, chewing fibrosis is triggered in 
the mucosal tissue. The presence of other additional factors (systemic factor, other 
local factors like chillies) might determine the onset and its severity. Once the dis-
ease is established, the tissue suffers from hypoperfusion due to fibrosis. Subse-
quently the copper clearance is further delayed in the tissue thereby increasing the 
local tissue copper concentration.
The initial symptoms (burning oral mucosa) often result in poor oral intake and mal-
nutrition which potentiate tissue fibrosis. The condition enters a vicious cycle when 
the mouth opening reduces progressively predisposing the patient to psychological 
as well as physical stress and further fibrosis. It is also speculated that the chronic 
exposure alters the absorption threshold of gut and increases the body resistance to 
the subtle higher level of copper. It is also showed that the drinking water with higher 
copper concentration may be well tolerated without any gastrointestinal symptoms.31 
Hence systemic adaptation to the marginal increase in copper level can be expected 
which leads to preconditioning the oral mucosa.
Testing the hypothesis
To test the hypothesis a careful investigation of copper level of potable water (com-
munity and home) and food is recommended. The concentrations can be correlated 
with serum and saliva copper levels. Additionally serum ceruloplasmin can validate 
the systemic predisposition.
Discussion
Among many trace elements associated with OSMF, role of copper and iron have 
been extensively studied and have been the subject of a multitude of investiga-
tions.32 There are many studies which showed the local action of copper in patho-
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genesis of OSMF. However, its systemic role is not been investigated. We postulate 
systemic exposure of copper from diet as an etiopathogenic factor. Though most of 
the studies have shown a normal blood and faecal values for copper in OSMF,13 still 
there are some studies which demonstrated increased systemic copper values in 
OSMF and in other fibrotic conditions.32 There is also an experimental evidence that 
increased dietary copper intake is linked to a direct increase in lysyl oxidase activi-
ty.10,33 Furthermore, the presence of copper consumed from other sources, such as 
copper cooking utensils, would be expected to produce at least sporadic cases of 
OSMF.34  This is supported by reports of Indian infantile cirrhosis, an ecogenetic 
copper-related fibrosis, which is not only independent of OSMF but is also found in 
Austrians who use similar copper made cooking vessels.34 Hence the role of sys-
temic copper can be speculated in OSMF and our hypothesis is instructive in ex-
plaining the typical features of the disease. Based on the hypothesis it can be con-
cluded that the preconditioned oral cavity is prone to bilateral fibrosis whereas no 
conditioning could lead to unilateral fibrosis only. It may also explain why there are 
reports of progression of disease even after cessation of areca chewing habit or 
medical treatment. After the cessation of the habit or medical therapy the compro-
mised oral mucosa is still exposed to residual copper from diet (which is absorbed 
due to an altered threshold) which is sufficient to precipitate the fibrosis further as 
bioavailability is relatively increased due to tissue hypoperfusion.
Conclusion
In spite of continued research the pathogenesis of OSMF is still obscure. Though 
there are various treatment modalities are available for the disease, recurrence re-
mained as major challenge. Hence it is advised to emphasize the identification and 
elimination of the causative factors of OSMF. This present hypothesis proposes a 
new predisposing factor which if proved promises a new horizon in helping to pre-
vent this devastating disease which is widespread in the Indian subcontinent and a 
prospective study is currently in progress.
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Abstract
We aimed to investigate the concentration of copper ions in drinking water and to 
assess whether copper has a role in the pathogenesis of oral submucous fibrosis 
(OSMF). We studied 50 patients with clinically and histologically diagnosed OSMF 
from the Yadgir district of Karnataka in India. Fifty healthy people matched for age 
and sex were used as controls. In both groups concentrations of copper ions in se-
rum, saliva, and home drinking water were measured using atomic absorption spec-
troscopy and intelligent nephelometry technology. Serum ceruloplasmin concentra-
tions were also estimated in both groups. The mean (SD) concentration of copper in 
the home drinking water of patients with OSMF was significantly higher (764.3 
(445.9) μmol/L) than in the controls (305.7 (318.5) μmol/L) (p < 0.001). Patients with 
OSMF also had significantly higher copper concentrations in serum and saliva, and 
serum ceruloplasmin than controls (p < 0.001). For the first time these data have 
shown a positive association between copper concentrations in home drinking water 
and OSMF. It raises the possibility that increased copper in drinking water contrib-
utes to the development of OSMF, and adds to that ingested when areca nut is 
chewed.
Keywords
Oral submucous fibrosis; Pathogenesis; Copper; Home drinking water
Introduction
Oral submucous fibrosis (OSMF) is a debilitating disease of the oral cavity that 
causes serious functional morbidity and an increased risk of malignancy.1,2 It was 
first described in 5 Indian women and was termed atrophia idiopathies (tropica) mu-
cosae oris (Schwartz J. Atrophia idiopathica (tropica) mucosae oris. Paper present-
ed at the Eleventh International Dental Congress. London, July 1952), submucous 
fibrosis of the palate and pillars,3-5 and later, submucous fibrosis.4 Its premalignant 
nature was first described by Paymaster in 1956.6
The disease is characterised by juxtaepithelial inflammation, fibroelasticity of the 
lamina propria, and epithelial atrophy. It can cause varying degrees of debility be-
cause of a burning mucosa, restricted mouth opening, and limited intake of food.7-9 
The signs and symptoms depend on the stage and site of involvement,7 and malig-
nancy has been noted among 7–30% of patients over a 17-year period.2,4,7 It is pre-
dominantly seen in South Asian developing countries, among Asian immigrants in 
the UK, and in south and east Africa,10 and consequently is considered a problem for 
global public health.2,11 In India the prevalence varies from 0.2% to 0.5% and a high 
percentage is found in the south of the country.12 It is mostly seen in the second or 
third decade, and recent data suggest a male predominance, however, both sexes 
are equally at risk.7
The exact cause is not known and is therefore the subject of speculation. Most au-
thorities suggest that it does not have a single cause but is multifactorial13; many 
different factors combine to induce disease and influence outcomes – for example, 
chewing betel nut or tobacco, smoking, eating chillies, malnutrition, vitamin defi-
ciency, autoimmunity, and genetic predisposition.13 However, there is growing evi-
dence that areca nut is the primary aetiological factor.10,14
Recently there has been interest in the role of copper in the pathogenesis of OSMF. 
Several clinical and experimental investigations have provided evidence of a casual 
relation between the copper found in areca nut and its association with OSMF.7,15-18 
It has been suggested that chewing areca nut significantly raises the concentration 
of soluble copper in saliva and thereby upregulates local lysyl oxidase activity in the 
oral mucosa, which promotes fibrogenesis by the cross-linking of collagen fibres.15,16
Copper is a trace metal essential for the function of several key enzymes involved in 
the human metabolism.16, 19 They include cytochrome-c oxidase, superoxide dis-
mutase, metallothionein, and lysyl oxidase.16 Genetic disorders such as Wilson dis-
ease, or environmental contamination that leads to the accumulation of copper in 
childhood cirrhosis and pulmonary fibrosis in India, can cause abnormalities in the 
absorption, metabolism, and excretion of copper, and result in it being deposited in 
several sites in the body.16,20 As high concentrations are seen in OSMF, it has be-
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come a subject of interest in the field of head and neck oncology. While most studies 
that involve copper have emphasised its local action on the oral mucosa, its sys-
temic effect in OSMF has also been shown.10,17,18
We aimed to investigate whether copper in drinking water has a role in the pathogen-
esis of OSMF.
Patients and methods
We obtained approval from the local ethical committee for a prospective case control 
pilot study. It was conducted in the Yadgir district of the Hyderabad–Karnataka re-
gion in India. Healthy patients native to the Yadgir district who had no serious medi-
cal history, and who had lived and worked in the same area since birth, were in-
cluded. Those who spent time away from home (including long distance drivers 
because they did not use their regular water supply at home), and those who had 
previously had operations for OSMF and had secondary oral changes, were ex-
cluded.
For the study group we recruited 50 patients with standard clinical symptoms of 
OSMF4 confirmed with oral biopsy examination, and matched them by age and sex 
with 50 healthy people who did not chew areca nut. Written consent was obtained. 
Samples of serum and saliva were collected in both groups to measure copper con-
centrations, and concentrations of ceruloplasmin were also measured. To avoid con-
tamination by areca nut, all patients in the study group were asked to avoid chewing 
it in any form for one hour, and a sterile plastic container was used to collect the 
unstimulated saliva. One of the authors collected and refrigerated samples of drink-
ing water (most came from bore holes and wells) from each patient’s home.
Copper in water was analysed using flame atomic absorption spectroscopy after the 
equipment was calibrated with standards for copper. According to World Health Or-
ganization (WHO), United States Environmental Protection Agency (USEPA), and 
Indian standard specification (IS 10500), the desirable concentration of copper in 
water is 31.85 μmol/L, and the standard limit is 828.03 μmol/L (data provided by 
University Agriculture Sciences, Raichur, India).
To estimate copper concentrations in serum and concentrations of ceruloplasmin we 
collected 5 ml of blood by venipuncture in a plain tube and froze the serum for trans-
portation. To collect mixed saliva samples patients rinsed their mouths with ultra-
pure water and spat into individual sterile plastic containers, which were then frozen 
for transportation. The volume of each whole mixed saliva sample was accurately 
measured, wet washed with 3.5 ml 60% nitric acid (HNO3) and 0.2–0.5 ml 60% per-
chloric acid (HClO4), then adjusted to a constant volume of 2.5 ml with the most pure 
water available. All chemicals were of the highest available purity. A beaker with nitric 
acid and a beaker of perchloric acid were prepared for each sample to test for purity 
and accidental contamination. We analysed serum, salivary copper, and serum ce-
ruloplasmin using intelligent nephelometry technology (MISPA-i, Agappe diagnos-
tics, Ernakulum, Kerala, India) with quality control (QC Passed no. 2160110056) 
smart card calibration, and verified the assay performance. Data were expressed in 
mean, standard deviation (SD), and percentage.
Comparisons between the two groups were done using Student’s t-test, z-test for 
proportion, and Pearson’s correlation coefficient. Probabilities of less than 0.05 were 
considered significant. Data were analysed using SPSS version 16.0 (IBM).
Results
The study included 100 male patients. The mean (SD) age of patients in the study 
group was 28.0 (6.9) years, and in the control group was 28.1 (8.1) years. The differ-
ence between ages in the 2 groups was not significant. There was a significant dif-
ference between the groups in the mean (SD) concentration of copper in water mea-
sured by atomic absorption (p < 0.001), and there were also significant differences 
in mean (SD) concentrations of serum copper, salivary copper, and ceruloplasmin 
between the groups (p < 0.001) ( Table 1). 
Table 1: Comparison between groups for serum ceruloplasmin, serum copper, 
salivary copper, and copper concentration in drinking water.
Group
Mean (SD) 95% CI of dif-
ference
p-Value
OSMF group Control group
Serum 
cerulo-
plasmin 
(mg/L)
57.3 × 10−5(16.6 × 10−5) 41.1 × 10−5(18.2 × 10−5) 9.24 × 10−5 to 
23.07 × 10−5
<0.001
Serum 
copper 
(μmol/L)
1.34 (0.57) 0.89 (0.39) 0.29–0.67 <0.001
Salivary 
copper 
(μmol/L)
4.65 (1.59) 2.74 (1.66) 1.25–2.54 <0.001
Copper 
in drink-
ing water 
(μmol/L)
764.3 (445.9) 305.7 (318.5) 261.2–598.7 <0.001
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Fig. 1.  Percentage of higher than average copper concentrations in OSMF and control 
groups (dark grey = OSMF; light grey = control)
Copper concentrations were high in the drinking water taken from the homes of 33 pa-
tients (66%) in the OSMF group and 8 patients in the control group (16%). Serum ceru-
loplasmin and copper concentrations were also high in 35 patients in the OSMF group 
(70%). Copper concentrations in saliva were higher than normal ranges in 36 patients 
(72%) (Fig. 1). Serum ceruloplasmin, and concentrations of copper in serum and saliva 
were above the normal range in 16 (32%), 15 (30%), and 17 (32%) patients with OSMF, 
respectively (Table 2). There was a positive correlation between concentrations of cop-
per in water and serum as well as in salivary copper in both groups (Table 3). 
Table 2: Number (%) of patients with high copper concentrations.
Table 3: Pearson’s correlation of copper concentrations in water with serum 
ceruloplasmin, serum copper, and saliva copper.
Discussion
Among many trace elements associated with OSMF, the role of copper ions has 
been studied extensively and has been the subject of many investigations.18 Copper 
is an essential trace element. The average daily intake of copper in adults in devel-
oped countries is between 0.6 and 1.6 mg, of which 35–70% is absorbed from the 
gastrointestinal tract.15
The intake of copper comes almost exclusively from food and water although a small 
amount comes from skin contact with substances that contain it,21 and its balance is 
normally controlled by efficient homeostatic mechanisms.19,21 Anecdotal reports from 
isolated occurrences in humans suggest that when drinks or drinking water are con-
taminated with copper it either causes no symptoms or causes abdominal pain, nau-
sea, vomiting, and diarrhoea. However, the threshold for gastrointestinal symptoms 
caused by excessive ingestion of copper has not been established in controlled 
prospective studies.21,22
Local mucosal exposure to copper by chewing areca nut is causally linked to OSMF.23 
The role of copper in OSMF is not clearly understood although it is known that the 
copper dependent enzyme lysyl oxidase, which is secreted by fibroblasts, facilitates 
the cross-linking of collagen, and inhibits its degradation.23, 24
Systemic exposure to copper through drinking water has been implicated in the 
pathogenesis of several fibrotic conditions,25 but its role in OSMF has not been ex-
amined previously. Trivedy et al.15 observed increased salivary copper and normal 
systemic copper concentrations in patients with OSMF. Based on the data they hy-
pothesised that chewing areca nut is the main source of local concentrations of cop-
per in the oral cavity and in salivary secretions.15 Nevertheless some studies have 
shown raised concentrations of copper and ceruloplasmin in the serum of patients 
with oral premalignant and malignant lesions, and OSMF.18,26,27
While there is a clear association between chewing areca nut, concentrations of 
salivary copper, and OSMF, the mechanism of generalisation of oral mucosal fibrosis 
and its heterogeneous pattern of occurrence have yet to be elucidated. It is interest-
ing to know the sporadic trend of occurrence of the condition and its diverse mucosal 
incidence irrespective of how often areca nut is chewed or where it is placed in the 
mouth. Trivedi et al.15 noted that mucosal fibrosis and increased salivary and muco-
sal copper concentrations developed at the site where patients habitually placed the 
quid. They hypothesised that the copper concentration is raised in tissue that is in 
contact with the quid and this results in fibrosis of the oral mucosa.15 However, it 
does not explain the bilateral incidence of OSMF in unilateral chewers, and early 
isolated fibrous bands that are seen around the lip (rima oris), tongue, and retromo-
OSMF group (n = 50) Control group (n = 50)
Serum ceruloplasmin 35 (70) 16 (32)
Serum copper 35 (70) 15 (30)
Salivary copper 36 (72) 17 (34)
Copper in drinking water 33 (66) 8 (16)
r-Value p-Value
OSMF group Control group
Copper in water and serum ceruloplasmin 0.90 0.90 <0.001
Copper in water and serum 0.80 0.88 <0.001
Copper in water and saliva 0.79 0.82 <0.001
56 57
lar or pterygomandibular tissue without involvement of the buccal mucosa (where 
the quid is commonly placed).2,4,28
It is possible that raised concentrations of systemic copper caused by regularly 
drinking water that contains high concentrations of copper ions has an important role 
in the pathogenesis of OSMF as suggested by our results. Chronic drinking or inges-
tion of copper may alter the normal threshold for the absorption of copper by the gut 
and may also change the body’s resistance to copper. When exposed to additional 
copper in areca nut, the cumulative effect could compound OSMF. This hypothesis 
might also help to explain the sporadic incidence and appearance of fibrosis in the 
oral mucosa, and could also explain bilateral disease in patients who chew only on 
one side. Our data have shown that the drinking water of patients with OSMF had a 
significantly higher copper concentration than that of the control group, and that pa-
tients with OSMF also had significantly higher mean serum copper and ceruloplas-
min concentrations.
Eight volunteers (16%) in the control group had raised copper concentrations in their 
drinking water, serum, and saliva. It could be postulated that they might have a high 
risk of developing OSMF if they started to chew areca nut, but further work is needed 
to understand the role of systemic copper in the pathogenesis of the condition. Fur-
ther research in this area is in progress to find the association in a large heteroge-
neous population and to ascertain whether the amount of water drunk is propor-
tional to the total copper concentration in serum, or whether it has a lesser role than 
the copper contained in areca nut.
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Abstract
Although oral submucous fibrosis (OSMF) is thought to be multifactorial in origin, the 
chewing of areca nut is thought to be the main cause. Alkaloids and tannins in areca 
nut are responsible for fibrosis, but recent evidence has suggested that copper ions 
are also an important mediator, and in a small pilot study we recently found that 
OSMF was significantly associated with a raised concentration of copper in drinking 
water. We have further investigated this association in a heterogeneous population 
in Hyderabad-Karnataka, India, a region with a high incidence of the condition. We 
evaluated 3 groups, each of 100 patients: those with OSMF who chewed gutkha, 
those who chewed gutkha but did not have OSMF, and healthy controls who did not 
chew gutkha. The difference between the groups in the mean concentration of cop-
per in water measured by atomic absorption spectrometry was significant (p < 0.001). 
There were also significant differences between the groups in mean concentrations 
of serum copper, salivary copper, and ceruloplasmin (p < 0.001). Our results confirm 
that copper in drinking water contributes to the pathogenesis of OSMF, but ingestion 
of copper is unlikely to be the sole cause.
Keywords
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Introduction
Oral submucous fibrosis (OSMF) is a potentially malignant disease that is seen pre-
dominantly in the Asian subcontinent.1 Its prevalence varies from 0.2% to 0.5% with 
a high percentage found in the southern part of India,2 and it affects more women 
than men, although reports of the sex ratio vary. The highest incidence occurs be-
tween the ages of 20 and 40 years.3 Many factors such as tobacco, smoking, pan 
masala, chili, malnutrition, vitamin deficiency, autoimmunity, and genetic predisposi-
tion, have been thought to contribute to the aetiology4,5 but areca nut is thought to be 
the main factor.4- 9
Gutkha is a commercial areca nut preparation containing the nut in high concentra-
tions along with tobacco and slaked lime. Over the last 10 years it has replaced 
other products that contained areca nut and tobacco. Consumption of the addictive 
gutkha is increasing rapidly, possibly because it is easily accessible and because of 
effective changes in price and marketing strategies.4 Alkaloids, tannins, and the cop-
per content of areca nuts are thought to be responsible for mucosal fibrosis.4
Copper may be the primary mediator of fibrosis because of up regulation of lysyl 
oxidase in both tissue biopsy specimens10 and OSMF fibroblasts.11 In vitro studies 
have found increased lysyl oxidase activity, as well as specific growth factors such 
as interleukin 1 (IL-1), transforming growth factor beta (TGF-b), insulin-like growth 
factor (IGF), and epidermal growth factor (EGF). The role of copper is also supported 
by the fact that patients with OSMF have raised concentrations in tissue, serum, and 
saliva.4,12- 15
A recent pilot study provided evidence that copper ions in drinking water have a role 
in the pathogenesis of OSMF, and the authors proposed that chronic ingestion of 
copper could lead to a systemic increase in its concentration and predispose the oral 
mucosa to OSMF.16 We have further investigated this in a large heterogeneous pop-
ulation from the Hyderabad-Karnataka (involving 6 districts) region of Karnataka, 
India.
Patients and methods
The Institutional Research Ethical Committee (Human) of Navodaya Medical Col-
lege and Hospital, Raichur, Karnataka, India approved this prospective case control 
study. Healthy patients native to the region with no serious medical history, and who 
had lived and worked in the same area since birth, were included. Those who spent 
time away from home (including long distance drivers because they did not use their 
regular water supply at home), and those who had previously had operations for 
OSMF and had secondary oral changes, were excluded. We advertised and organ-
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ised several clinics across the Karnataka district for patients with OSMF to attend.
For the study group we recruited 100 patients with standard clinical symptoms of 
OSMF17 confirmed by clinical examination (OSMF group), and matched them for age 
and sex with 100 healthy people who chewed gutkha but did not have OSMF (non-
OSMF group) and 100 healthy people who did not chew gutkha (control group). 
Written consent was obtained from all patients. Serum and saliva samples were col-
lected in all groups to assay concentrations of copper and ceruloplasmin. To avoid 
contamination by areca nut, all patients were asked to avoid chewing it in any form 
for one hour before saliva was collected. Patients rinsed their mouths with ultra-pure 
water and spat into individual sterile plastic containers, which were then frozen for 
transportation.
To estimate the concentrations of copper and ceruloplasmin, 5 ml of venous blood 
was collected in a plain tube and frozen for transportation. One of the authors col-
lected and refrigerated samples of drinking water (most originating from bore holes, 
municipal taps, and wells) from each patient’s home.
Laboratory analysis
Copper in water was analysed using flame atomic absorption spectroscopy after the 
equipment was calibrated with standards for copper. According to the World Health 
Organization (WHO), the United States Environmental Protection Agency (USEPA), 
and Indian standard specification (IS 10500), the desirable concentration of copper 
in water is less than 31.85 μmol/L and the maximum limit is 828.03 μmol/L (data 
provided by University Agriculture Sciences, Raichur, India).
The volume of each whole mixed saliva sample was accurately measured, wet washed 
with 3.5 ml 60% nitric acid and 0.2–0.5 ml 60% perchloric acid, then adjusted to a con-
stant volume of 2.5 ml with pure water. Serum and salivary copper, and serum cerulo-
plasmin were analysed using intelligent nephelometry technology (MISPA-i, Agappe di-
agnostics, Ernakulum, Kerala, India) with quality control (QC Passed no. 2160110056) 
smart card calibration, to verify the performance of the assay.
The mean (SD) and percentages for each group were recorded. Comparison be-
tween groups was calculated using ANOVA for parametric distribution and a post hoc 
Dunnett’s test. Pearson’s rank correlation coefficient (r) was used to assess associa-
tion between variables within each group. Probabilities of less than 0.05 were con-
sidered significant. Data were analysed with the help of SPSS version 19.0 (IBM 
Corp).
Results
The study included 300 male patients. We encountered men only in our clinics be-
cause local social circumstances made women reluctant to attend. Mean (SD) ages 
are shown in Table 1. 
The mean copper concentration in water measured by atomic absorption differed 
significantly between the groups (p < 0.001). Significant differences between the 
groups were also found in mean
Table 1. Comparison of age between groups. Data are mean (SD).
concentrations of serum copper, salivary copper, and ceruloplasmin (p < 0.001) 
(Table 2). Copper concentrations were higher than normal in the home drinking wa-
ter of 33 patients in the OSMF group and 8 in the control group (Fig. 1). Serum cop-
per and ceruloplasmin concentrations were also higher than normal (normal range 
0.48–0.92 μmol/L; 20 × 10−5 and 60 × 10−5 mg/L, respectively) in the OSMF group 
(37% and 35%, respectively) and the control group (19% and 17%, respectively) 
(Fig.1). A total of 85 patients in the OSMF group and 8 in the control group also had 
higher than normal concentrations of copper in saliva (Fig. 1).
All those in the non-OSMF group had values within standard limits for serum 
ceruloplasmin and for concentrations of copper in serum and water, but they all had 
higher than normal concentrations of copper in saliva (n = 100) (Fig. 1).
There was a positive correlation between copper concentrations in water and 
serum and salivary copper in the OSMF group and the control group (Table 3) (p< 
0.001).
Discussion
Our previous pilot study16 showed a significant association between OSMF and cop-
per in drinking water, and serum and salivary copper. The present study conducted 
on a larger series of 300 patients has confirmed this. It is thought that copper stimu-
lates the activity of lysyl oxidase, an enzyme essential to the final cross-linking of 
collagen fibres. Increased concentrations of copper have been seen in mucosa af-
fected by OSMF, and this enhancement of lysyl oxidase activity supports its role in 
fibrogenesis.10,11
OSMF group  
(Gutkha with OSMF)
Non-OSMF group 
(Gutkha without OSMF)
Control 
group
p value
Age (years) 29 (8) 29 (7) 28 (7) 0.59
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Table 2. Comparison between the groups for all variables. Data are mean (SD).
*  p < 0.05 compared with control group.
**p < 0.01 compared with control group.
Dunnett›s test or Dunn›s test used after analysis of variance (ANOVA).
Copper is found in natural deposits in ores that contain other elements.18 It is a nutri-
ent essential for the function of several key enzymes involved in the human metabo-
lism4 including cytochrome-c oxidase, superoxide dismutase, metallothionein, and 
lysyl oxidase.16 It is rarely found in water sources, but drinking water in the home can 
often be contaminated by the corrosion of copper piping and cannot be directly de-
tected or removed.18 Mining and smelting operations, and municipal incineration may 
also contaminate supplies.18 This may be one reason why OSMF is typically found in 
low socioeconomic populations which may be exposed to contaminated water, and 
it also explains the high incidence of OSMF in developing countries where standards 
and regulations for the quality of drinking water are low.
Table 3. Pearson’s correlation (r-value) of copper in water with serum  
ceruloplasmin, salivary copper, and serum copper.
**p < 0.001.
In vitro work has found that raised copper concentrations increase the proliferation of fi-
broblasts.12 If this were the case then raised concentrations would be expected to cause 
mucosal fibrosis in all who chew gutkha, but many do not develop the condition.
Recently, the concept of “mucosal pre-conditioning”16 was introduced to explain why 
this might be the case. Chronic exposure to higher than normal concentrations of 
copper in drinking water might predispose the oral mucosa to OSMF, alter the nor-
mal threshold for its absorption, and change the cellular resistance to copper. When 
exposed to the additional copper in areca nut, the cumulative effect could compound 
the condition.16
Fig. 1.  Number of patients (n = 100) with high concentrations of copper (dark grey = OSMF 
group, medium grey = non-OSMF group, light grey = control group).
Local exposure of the mucosa to copper when areca nut is chewed is causally linked 
to OSMF,4 and systemic exposure from drinking water with high concentrations of 
copper has been implicated in the pathogenesis of several fibrotic conditions.19 
Some studies have found that concentrations of serum copper are directly propor-
tional to the increase in the severity of OSMF,15,20 although Trivedy et al.19 reported 
increased salivary copper and normal systemic concentrations in patients with 
OSMF. It seems that raised concentrations of copper and ceruloplasmin are found in 
some patients with premalignant and malignant oral lesions, and OSMF.21-23
We found that the mean concentration of copper in water was higher in the OSMF 
group than in both the other groups (Fig. 2) although it was at the upper end of nor-
mal, which might explain the absence of any toxic effects. 
We noticed that concentrations of copper in drinking water were lowest in the non-
OMFS group (Fig. 2). One possibility is that low concentrations of total body copper 
spare the oral mucosa from pre-sensitisation (or pre-conditioning) to OSMF. The 
mean concentration of serum ceruloplasmin was highest in the OSMF group, which 
again may be because of the raised concentrations of serum copper in patients with 
OSMF group (Gutkha with 
OSMF)
Non-OSMF group 
(Gutkha without 
OSMF)
Control group p value
Serum copper 
(μmol/L)
1.02 (0.53)** 0.34 (0.15)** 0.60 (0.41) <0.001
Serum cerulo-
plasmin (mg/L)
51.43 × 10−5 (16.1 × 10−5)** 26.3 
×10−5 (8.63 × 10−5)
37.69 × 10−5(16.74 × 10−5) <0.0001
Salivary cop-
per (μmol/L)
4.81 (1.17)** 4.41(0.401)** 2.41 (1.41) <0.0001
Water copper 
(μmol/L)
388.53 (229.23)** 203.82 (82.80)* 267.51 (165.60) <0.004
OSMF group (Gutkha 
with OSMF)
Non-OSMF group (Gutkha 
without OSMF)
Control 
group
Serum cerulo-
plasmin
0.727** −0.037 0.715**
Salivary copper 0.419** 0.122 0.708**
Serum copper 0.854** −0.14 0.828**
66 67
OSMF who chewed gutkha (Table 2). Concentrations of salivary copper were higher 
than normal in both groups that chewed gutkha (85% of the OSMF group and all 
those in the non-OSMF group) (Fig. 1), which suggests that copper from the gutkha 
or areca nut constantly leaches into the saliva, but the oral mucosa responds differ-
ently.
Fig. 2.  Comparison of copper concentrations in water between groups
We can speculate that the oral mucosa in patients with OSMF may have been pre-
sensitised or conditioned by chronic raised concentrations of copper in water, or that 
a threshold of total copper is needed to trigger the condition. Concentrations of sali-
vary copper were within normal ranges in the control group as there was no source 
of local copper (gutkha or areca nut) in the oral cavity (Fig. 3). It can be inferred that 
chronic ingestion of copper has a vital role in the pathogenesis of OSMF. As far as 
we are aware, this is the first study to evaluate serum and salivary copper concentra-
tions in people who chew gutkha but do not have OSMF, which are likely to be the 
best controls in research into this condition. They had normal serum values and cop-
per in drinking water caused no problem. However, concentrations of salivary copper 
were persistently higher than normal (Fig. 1), which indicates that the copper content 
of gutkha is not the only cause of oral mucosal fibrosis.
Conclusion
This large study shows a positive correlation between the incidence of OSMF and 
concentrations of copper in drinking water. It also provides evidence that locally 
available copper in saliva is not the only cause of OSMF but may affect sensitised 
mucosa. This could explain why some people who constantly chew gutkha or areca 
nut do not develop the condition. Undoubtedly, other factors are necessary to initiate 
fibrosis, and copper may be just one variable. OSMF may affect people in develop-
ing countries and those of low socioeconomic status because drinking water can be 
contaminated with copper (and other trace elements) which we consider to be an 
important contributing factor. To reduce its incidence, high standards of drinking wa-
ter must be maintained, and we recommend that all public water supplies meet those 
set out in the National Primary Drinking Water Regulations.24
Ethics statement/confirmation of patient permission: Institutional research ethi-
cal committee (Human) of Navodaya medical college and Hospital Raichur.
Funding: This study was generously supported by an endowment grant (2012) from 
the BAOMS.
Fig. 3.  Comparison of copper concentrations in saliva between groups.
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Abstract
Despite extensive research, the pathophysiology of oral submucous fibrosis (OSMF), 
a premalignant condition that primarily affects the mucosa, is still unclear, although 
the chewing of areca nut is known to be the primary cause. While a clear association 
exists between areca nut and OSMF, very little has been published on the reason for 
its sporadic incidence in the mouth. Many authors have suggested the site where 
quid is habitually placed, but this fails to explain multiple sites in those who chew on 
one side. We hypothesised that the pattern of salivary pooling might affect the distri-
bution of OSMF by carrying the chemicals responsible for mucosal damage. In our 
study of 174 patients, we evaluated the sites where quid was habitually placed and 
the areas of salivary pooling, and their association with the incidence of OSMF. Most 
chewers (136/174, 78%) placed the quid in the buccal vestibule, although other sites 
were also used including the vestibule of the lip, tongue, and floor of the mouth. The 
standardised residuals suggested significant associations (p < 0.001) between sali-
vary pooling and OSMF, and indicated that salivary pooling affects the mucosal sur-
faces where it occurs. Our results show that the quid is not the only cause of OSMF. 
Salivary pooling also has an important role and provides a possible mechanism for 
the sporadic incidence of the condition. To our knowledge this is the first study to 
evaluate salivary pooling as a contributory factor in OSMF, and it may help to explain 
the pattern of distribution. Further work is needed in this area to understand the as-
sociation more fully
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Introduction
Oral submucous fibrosis (OSMF) is a complex, debilitating, and precancerous condi-
tion that is associated with abnormal metabolism of collagen.1 Despite more than 3 
decades of research, its pathogenesis is still not fully understood,1,2 and although it 
is thought to be multifactorial with many influencing factors, areca nut is considered 
the primary cause.3–8
Areca nut contains alkaloids, flavonoids, and copper, which interfere with homeosta-
sis of the extracellular matrix.1 Many studies provide evidence of a casual associa-
tion between OSMF and copper in areca nut and drinking water,3,8–12 and it has been 
suggested that chewing arecanut substantially raises the concentration of soluble 
copper in saliva, and as a consequence upregulates local lysyl oxidase activity in the 
oral mucosa, and promotes fibrosis by the cross-linking of collagen fibres.8
In south Asia, the most commonly used, commercially freeze-dried areca nut 
products are betel quid and gutkha, the latter having replaced most areca nut 
preparations. Gutkha contains high concentrations of areca nut along with to-
bacco,1 and when chewed, dissolves quickly in saliva and provides central stimu-
lation, which is reported to be more intense than tobacco alone.1 It is usually 
placed in the buccal or labial vestibule, and is sometimes placed sublingually, 
and is chewed for up to an hour until the nut softens and dissolves in saliva. The 
excess is then spat out or swallowed. Some patients have been known to place 
it in the buccal vestibule while they sleep. As increased copper concentrations 
have been found in fibrotic tissue in patients with unilateral OSMF, it has been 
postulated that chewing at the site where the quid is habitually placed raises the 
local levels of copper sufficiently to cause fibrosis.13,14
While there is a clear association between the chewing of gutkha or areca nut and 
the incidence of OSMF, 10,11 we know of little that has been published on the cause of 
its sporadic pattern of distribution in the oral cavity. Persistent chewing of gutkha 
quid at a specific site has been suggested as the reason for the diverse distribution 
of OSMF. According to this hypothesis unilateral chewers will have unilateral OSMF. 
However, this postulation is based on experimental data rather than clinical observa-
tion.9-11
It has been proposed that proximity of the gutkha or areca quid to the oral mucosa is 
responsible for the local development of OSMF, and experimentally, exposure of the 
oral mucosa to saliva containing dissolved products of the quid has resulted in 
OSMF.10,11 Based on these findings, it was postulated that gutkha quid and saliva 
containing its chemicals are the primary cause of OSMF because they enable the 
chemicals to be absorbed into the oral mucosa.10, 11 However, this fails to explain the 
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incidence of OSMF in multiple sites among unilateral chewers, and why some sur-
faces are not affected.
The prolonged exposure of the oral mucosa to saliva containing dissolved products 
of the quid, which occurs when the saliva pools in a specific area, could be an expla-
nation. It could therefore be speculated that the pattern of pooling affects the distri-
bution of OSMF. We recorded the sites where gutkha was chewed and where the 
saliva pooled to find out whether they were associated with the site of OSMF.
Material and methods
The local ethics committee approved the study which was conducted in the Yadgir 
district of the Hyderabad–Karnataka region in India. We randomly recruited 174 pa-
tients who chewed gutkha or areca nut, and had had OSMF confirmed by clinical 
examination by one of the authors of the study (GA). We avoided histopathological 
examination because the pain that results from the biopsy procedure can change the 
patterns of chewing and salivary pooling. We therefore followed the standard proto-
col for clinical diagnosis by Khanna and Andrade.15
Those previously operated on for OSMF and those who had OSMF but were not 
currently chewing gutkha, were excluded. Patients were informed only during the 
examination to avoid influencing the site of salivary pooling. They were given a de-
tailed explanation about the placement of gutkha quid and sites of salivary pooling in 
their native language. Salivary pooling was described as the collection of pooled 
saliva under pressure in one part of the oral cavity during the process of chewing, 
and that the surface where this occurred contained a high concentration of the gut-
kha ingredients. For convenience we divided the oral mucosal surfaces into 6 cate-
gories: right buccal mucosa, left buccal mucosa, tongue, lip, floor of the mouth, and 
back of the mouth.
Each patient (holding the gutkha quid for 5 min) was shown the 6 areas in a healthy 
volunteer and questioned about where they placed the quid and about the surfaces 
affected by salivary pooling. These were recorded by one of the authors (GA) and a 
panel of 3 examiners (medical physiology staff) examined patients repeatedly to as-
sess the sites. Histopathological examination of all the surfaces involved in this large 
group was beyond the scope and aims of the study.
We recorded the patient’s age and occupation, and recorded isolated cases of 
OSMF separately with the site where quid was placed and surfaces where saliva 
pooled. Any secondary malignant changes in the mucosal surfaces were confirmed 
histopathologically and recorded separately for each site involved.
Statistical methods
The nominal (categorical) data were analysed and assessed for association between 
the site where quid was habitually placed, site of salivary pooling, and clinically af-
fected area. The chi-square test with Yates’ continuity correction for 2 × 2 contin-
gency tables was used to analyse association between groups. The chi square test 
is an approximate test, and Yates’ correction for continuity should make it more ex-
act, specifically in small samples. It makes the result more conservative, which is 
thought to be beneficial because of the interdependence of the cells in a 2 × 2 table. 
The correction subtracts 0.5 from the difference between each served and expected 
value and therefore reduces the size of the test statistic and increases the probabil-
ity value. While its use for large samples makes little difference to the outcome of the 
chi square test, it has been applied here to show that significant associations were 
identified with the most conservative application of the test. Probabilities of less than 
0.05 were considered significant. Data were analysed using SPSS Statistics for Win-
dows (version 20.0, IBM Corp, Armonk, USA).
Results
A total of 174 men, mean (SD) age 26.0 (8) years were included. Quid was most 
commonly placed in the left buccal mucosa (79/174, 45%) followed by the right buc-
cal mucosa (57/174, 33%), the lower labial vestibule (23/174, 13%), ventral surface 
of the tongue or lingual sulcus (8/174, 5%), and anterior two-thirds of the tongue 
(7/174, 4%) (Table 1). While salivary pooling occurred mostly at each placement site, 
other sites were also found (Table 2). 
The clinical diagnosis of OSMF followed the pattern of salivary pooling in all patients 
(Table 1) and showed a significant association (p < 0.001). All 22 cases of isolated 
OSMF were associated with areas where the quid was placed and where the saliva 
pooled, which indicated that the site of chewing site was a primary site of OSMF ( 
Table 3). 
In 21 patients (12%) who were concerned about their appearance and needed com-
munication skills as part of their occupation (including doctors and software engi-
neers) we often found salivary pooling and OSMF in the posterior surface of the oral 
cavity. A total of 5 patients presented with histologically confirmed malignant trans-
formation.
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Discussion
Our results show that the sites where areca nut is chewed and saliva collects are 
important factors in the distribution of OSMF. Particles of gutkha are reduced in size 
by chewing and softened by saliva. The effects of salivary pooling depend on the 
permeability and absorptive capacity of the oral mucosa, which is not generally con-
sidered to be an effective barrier to the penetration of substances.16 Its permeability 
is related to the thickness and degree of keratinisation and from the sublingual to the 
buccal and palatal mucosa, permeability decreases.16,17 
Table 2:  Placement of quid and sites of salivary pooling.
Table 3: Isolated oral submucous fibrosis (OSMF),  
placement of quid, and salivary pooling.
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Place-
ment of 
quid
No. of 
patients 
(n = 174)
Site of pooling
Right 
buccal 
mucosa
Left 
buccal 
mucosa
Tongue Lip Floor of 
mouth
Back 
of 
mouth
Total
Right 
buccal 
mucosa
57 57 44 6 11 4 20 142
Left 
buccal 
mucosa
79 43 79 4 10 5 34 175
Tongue 7 4 7 7 1 3 7 29
Lip 23 7 9 23 5 2 8 54
Floor 
of the 
mouth
8 4 7 3 6 8 4 32
Total 174 115 146 43 33 22 73 432
Isolated OSMF No. of patients Placement of quid Salivary pooling
Left buccal mu-
cosa
14 Left buccal mucosa Left buccal mucosa
Right buccal 
mucosa
6 Right buccal mucosa Right buccal mucosa
Lip 2 Lower lip Lower lip, left buccal 
mucosa
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As the buccal mucosa is less permeable than the sublingual mucosa, it is a favour-
able route of sustained delivery of gutkha ingredients. It is also the most convenient 
site to place the gutkha,16 and can therefore be considered the most vulnerable sur-
face for OSMF. The rapid absorption of gutkha in the lingual sulcus results in an 
early loss of its taste so the site might not be preferred by the patient subconscious-
ly.16 Placing betel quid in other sites than the buccal mucosa may hinder speech and 
interestingly, patients who preferred these less common sites (lip, tongue, and floor 
of the mouth) had occupations that required little use of speech (garage workers, 
drivers, night duty watchman, and carpenters). In those with occupations that re-
quired a good appearance and verbal communication skills, saliva pooled in the 
posterior surface to mask the appearance of chewing, and in them OSMF affected 
the soft palate, and facial and retromolar tissue.
In our study, fibrosis most commonly affected the site where the quid was placed and 
was also more severe (in terms of number of fibrotic bands, burning sensation, ero-
sion and fragility) than in other areas. It is likely that the pool of saliva containing 
concentrated gutkha grains initiates an early fibrotic reaction.
However, OSMF was also found where salivary pooling was absent, but these pa-
tients gave an earlier history of salivary pooling in these areas before fibrosis had 
occurred. It could be speculated that the pattern of pooling changed when the muco-
sal surface became fibrosed, which would reduce the absorption of the quid, and the 
change continued until all the oral surfaces had been affected by OSMF.
There was no isolated fibrosis in the mucosa of the upper lip, but fibrosis was always 
preceded by OSMF of the lower lip. This may be caused by gravity, which makes it 
a favourable site to place the gutkha, and the upper lip may be spared because it is 
protected by the upper incisors when present.
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Chapter 7
Summary, Conclusions and  
future perspectives
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Summary
This thesis is based on studies that evaluated the role of copper concentrations in 
drinking water in the pathogenesis of oral submucous fibrosis (OSMF), and also the 
role of saliva pooling in the sporadic incidence of OSMF on oral mucosa. The re-
search was conducted in the northeastern region of Karnataka, India through the 
support of endowment grants by the British Association of Oral and Maxillofacial 
Surgery (BAOMS), London, UK under the supervision of Professor Matthias A.W. 
Merkx from Radboud University of Nijmegen, The Netherlands, and Professor Peter 
A. Brennan from the University of Portsmouth, UK. The undertaken research is pre-
mised on the fact that OSMF affects only few areca nut-chewing individuals, who 
exhibit only sporadic incidences irrespective of the chewing site in the oral cavity. 
The hypothesis was that raised concentrations of systemic copper, caused by the 
regular consumption of drinking water that contains high concentrations of copper 
ions, plays an important role in the pathogenesis of OSMF. It was also postulated 
that the pattern of salivary pooling affects the distribution of OSMF.
The study objectives were:
• To review the existing literature on OSMF, and discuss the various aspect of 
the condition 
• To hypothesize possible mechanisms of OSMF development through di-
etary copper
• To evaluate the possible role of copper in drinking water in the pathogenesis 
of OSMF through a pilot study 
• To assess the relationship between copper in drinking water and OSMF 
through a prospective case control study 
• To analyze salivary pooling as a contributory factor in OSMF pathogenesis, 
and to assess its role in the pattern of the disease distribution 
Chapter 1 presents the rationale of the study. Oral sub mucous fibrosis (OSMF) is a 
devastating condition of the oral cavity causing progressive scarring of the oral mu-
cosa, which results in progressive reduction of mouth opening. Eventually, patients 
experience difficulties in swallowing, which then severely affect body nutrition. As the 
disease progresses, it may cause speech & hearing defects as well as defective 
gustatory sensations. The fibrous tissue in the faucial pillars diverges from a slight 
submucosal accumulation in both pillars to a dense fibrosis extending deep into the 
pillars, with strangulation of the tonsils. It is this dense fibrosis involving the tissue 
around the pterygomandibular raphae that causes varying degrees of difficulty in 
mouth opening. Until recently, it was thought to be locally restricted to the Indian 
subcontinent, China and other regions of South East Asia, but is now considered to 
be of global importance due to large numbers of migrant populations also demon-
strating the condition. Moreover, the incidence of OSMF is on the rise in a younger 
age group in India, thereby spreading through in India in a rapid and seemingly un-
controllable manner. It is considered as a pre-malignant stage of oral cancer and 
reported as a significant risk of malignant transformation (7.6%).
Although six decades have passed after the condition was first described, there is 
still no apparent cure that has been proven as effective beyond doubt. In spite of 
relentless research, there are ongoing controversies regarding pathogenesis, and 
certain aspects of existing treatment modalities still need to be considered as ques-
tionable. This may be due to the fact that the disease is complex and multifactorial in 
origin. Existing research data can currently explain only some aspects of this multi-
faceted condition, and there may be many other factors which are presently over-
looked and need to be elucidated. 
Without doubt, OSMF is a crippling disease albeit without immediate life-threatening 
consequences. However, it does pose a great long-term threat as large segments of 
society could be afflicted by oral cancer in the future. 
As a result of the above mentioned considerations, the following research questions 
were formulated: 
• Why does OSMF frequently progress even after the cessation of the areca-
chewing habit?
• Why does OSMF recur even after medical therapy, and in the absence of 
areca -chewing?
• Why is the condition of OSMF predominantly witnessed among populations 
with low socioeconomic status, and geographically distributed across a belt 
of developing countries? 
• What is the extent of the possibility that the copper in the areca nut may be 
participating in the pathogenesis of OSMF?
• If the copper contained in the areca nut is the primary cause of OSMF, why 
are not all areca nut-chewers affected by the condition? 
• Is there any possibility of oral mucosa being exposed to copper through a 
systemic route? 
• Why do some areca nut -chewers develop OSMF in an early phase of their 
habit?   
• What is the reason for the occurrence of OSMF in multiple sites among uni-
lateral chewers? 
Chapter 2 reviews the current literature on OSMF. It reviews and discusses all com-
ponents of OSMF, including the terminology, presentation, aetiology, and pathogen-
esis, and provides a brief overview of its management. OSMF has been documented 
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since 1952 and is thought to be multifactorial in origin, with a high incidence in peo-
ple who chew areca nut; moreover, with a significant malignant transformation rate 
(7–30%), it poses global challenges for public health. Formerly confined to the Indian 
subcontinent, it is now often seen in the Asian populations of the United Kingdom, 
the USA, and other developed countries, therefore presenting a serious problem for 
global health. There is compelling evidence that the areca nut plays a primary role in 
the development of OSMF. A range of case–control studies have given convincing 
evidence that there is a definite dose-dependent correlation between consumption 
of areca nut and causation of the disease. The onset of the disease is directly pro-
portional to the concentration, incidence, and duration of chewing the nut. The high 
concentration of copper in areca nut has been found to stimulate lysyl oxidase activ-
ity, an enzyme essential to the final cross-linking of collagen fibres. Increased copper 
has been observed in mucosa affected by OSMF, which supports its role in fibrogen-
esis by enhancing lysyl oxidase activity. However the hypothesis, loss of equilibrium 
of extracellular matrix and continuous deposition of extracellular matrix in OSMF is 
currently well accepted. It seems that changes occuring in the extracellular matrix 
are likely to play a key role. Nevertheless, oral submucous fibrosis (OSMF) seems to 
be surrounded by unending enigma. Despite research spanning more than three 
decades, its pathogenesis is still not fully understood. There is consequently an im-
mediate and urgent need to wisely invest in research to precisely identify the various 
contributing or promoting factors of OSMF which also affect disease progression and 
treatment outcomes. 
Chapter 3 presents a hypothesis to explain preconditioning of the oral mucosa, 
which may play an important role in pathogenesis of OSMF. Various hypotheses put 
forward to date to elucidate the pathogenesis of OSMF have not been proven con-
clusively, and the precise mechanism of copper-mediated pathogenesis of fibrosis 
still remains elusive. Most studies on OSMF have focused only on the oral copper 
availability and its local mucosal action. An equally important second aspect to be 
considered is the pre-conditioning of the oral mucosa by a prolonged, chronic copper 
exposure. The results of existing studies in the literature raise the questions of why 
the disease progresses even after the cessation of the areca-chewing habit, and 
why there is a recurrence even after medical therapy and in the continued absence 
of areca chewing. This present study postulates that the chronic exposure to a diet 
containing a high-normal copper concentration (through food or copper-contaminat-
ed potable water) predisposes the oral mucosa to OSMF. This was explained through 
two overlapping pathways, namely the alteration of normal salivary copper concen-
trations by increased secretion, and the preconditioning of the oral mucosa through 
chronic exposure to salivary copper. Mucosal fibrosis may be initiated when the 
preconditioned oral mucosa face additional copper challenges from areca nut-chew-
ing. The presence of additional factors (such as systemic factors, or other local fac-
tors like chillies) might determine the onset and its severity. Once the disease is es-
tablished, the tissue suffers from hypoperfusion due to fibrosis. Subsequently, the 
copper clearance may be further delayed in the tissue, thereby increasing the cop-
per concentration in the local tissue, causing progression of the fibrosis. The condi-
tion enters a vicious cycle when the mouth opening reduces progressively, subse-
quently predisposing the patient to psychological as well as physical stress and 
further fibrosis. To test the hypothesis, a careful investigation of the copper concen-
tration in drinking water (community and home) and food is recommended. The con-
centrations can be correlated with serum and saliva copper levels. Additionally, se-
rum ceruloplasmin may validate the systemic predisposition.
Chapter 4 describes a pilot investigation to assess whether copper in drinking water 
plays a role in the pathogenesis of OSMF. The pilot sample was comprised of 100 
individuals from the Yadgir district of Karnataka in India, where the study was con-
ducted. This included 50 patients who were clinically and histologically diagnosed 
with OSMF, and therefore served as the study group. For the control group, 50 
healthy people matched by age and sex, were recruited. Both groups were tested for 
copper concentration in serum and saliva. Copper ion concentration in drinking wa-
ter was measured using atomic absorption spectroscopy and intelligent nephelom-
etry technology. The mean (SD) concentration of copper in the home drinking water 
of patients with OSMF was significantly higher (764.3 ± 445.9 µmol/L) than in the 
controls (305.7 ± 318.5 µmol/L) (p < 0.001). Patients with OSMF also had signifi-
cantly higher copper concentrations in serum and saliva, and serum ceruloplasmin 
than controls (p < 0.001). The data showed a positive association of copper in drink-
ing water with OSMF. It raised the possibility that the high-normal copper in drinking 
water may contribute to the development of OSMF, and adds to that level of inges-
tion when areca nut is chewed. Noticeably, eight volunteers (16%) in the control 
group had raised copper concentrations in their drinking water, serum, and saliva. It 
was postulated that they might have a high risk of developing OSMF if they started 
to chew areca nut, but further work was recommended to understand this associa-
tion in a large heterogeneous population, and in order to ascertain whether the 
amount of consumed water is proportional to the total copper concentration in se-
rum, or whether it has a lesser role than the copper contained in the areca nut. 
Chapter 5 covers a prospective case control study conducted in response to signifi-
cant results of the pilot study, which provided evidence that copper ions in drinking 
water play a role in the pathogenesis of OSMF. The association was further investi-
gated in a large heterogeneous population from the Hyderabad- Karnataka (involv-
ing 6 districts) region of Karnataka, India. The study evaluated 3 groups, each con-
sisting of 100 patients: those with OSMF who chewed gutkha, those who chewed 
gutkha but did not have OSMF, and healthy controls who did not chew gutkha. All 
three groups were subjected to investigations for copper concentration in serum, 
saliva and also copper concentration in drinking water. This was the first study to 
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evaluate serum and salivary copper concentrations in people who chew gutkha but 
do not have OSMF, which are likely to be the best controls in research into this con-
dition. The mean concentration of copper in water was higher (388.53 ±229.23 
µmol/L) in the OSMF group than in both the other groups. The concentrations of 
copper in drinking water were lowest in the non-OMFS group (203.82± 82.80 µmol/L). 
Significant differences between the groups were also found in mean concentrations 
of serum copper, salivary copper, and ceruloplasmin (p < 0.001). Serum copper and 
ceruloplasmin concentrations were higher than normal in the OSMF group (37% and 
35%, respectively) and the control group (19% and 17%, respectively). All non-OS-
MF areca nut chewers had values within standard limits for serum ceruloplasmin and 
for concentrations of copper in serum and water, but they all had higher-than-normal 
concentrations of copper in saliva (n=100). There was a positive correlation between 
copper concentrations in water and serum and salivary copper in the OSMF group, 
and the control group. The study conducted on a larger series of 300 patients has 
confirmed the significant association between OSMF and copper in drinking water, 
which supported the concept of “mucosal pre-conditioning”. Chronic exposure to 
high-normal concentrations of copper in drinking water might alter the normal thresh-
old for its absorption, change the cellular resistance to copper, and predispose the 
oral mucosa to OSMF. When exposed to the additional copper in areca nut, the cu-
mulative effect could compound the condition. It was also found that concentrations 
of salivary copper were higher than normal in both groups that chewed gutkha (85% 
of the OSMF group and all those in the non-OSMF group), which suggests that cop-
per from the gutkha or areca nut constantly leaches into the saliva, but that the oral 
mucosa responds differently. It may be possible that the oral mucosa in patients with 
OSMF may have been preconditioned by chronic raised concentrations of copper in 
water, or that a threshold of total copper is needed to trigger the condition. On the 
whole, this large study showed a positive correlation between the incidence of OSMF 
and concentrations of copper in drinking water. It also provided a hint that locally 
available copper in saliva might not be the only cause of OSMF but may affect sen-
sitized mucosa. This could explain why some people who constantly chew gutkha or 
areca nut do not develop the condition.
Chapter 6 demonstrates a study with the objective of assessing the role of saliva 
pooling in sporadic pattern of distribution of OSMF in the oral cavity. The studies 
from previous chapters provided sufficient data about mucosal preconditioning and 
its vulnerability to OSMF when exposed to areca nut challenge. However, the phe-
nomenon of preconditioning was less instructive in explaining the incidence of OSMF 
in multiple sites among unilateral chewers, and why some surfaces are not affected. 
Hence the study was aimed to elucidate the reason for the diverse distribution of 
OSMF. It was postulated that prolonged exposure of the oral mucosa to saliva con-
taining dissolved products of the quid, which occurs when the saliva pools in a spe-
cific area, could cause of fibrosis. It could therefore be speculated that the pattern of 
pooling affects the distribution of OSMF. The study included 174 OSMF patients of 
Yadgir district of the Hyderabad–Karnataka, India. Each patient (holding the gutkha 
quid for 5 min) was shown the 6 areas in a healthy volunteer, and questioned about 
where they placed the quid and about the surfaces affected by salivary pooling. 
These were recorded by one of the authors, and a panel of 3 examiners (medical 
physiology staff) examined patients repeatedly to assess the sites. The sites where 
gutkha was chewed and where the saliva was pooled, were recorded to find out 
whether these were associated with the site of OSMF. The clinical diagnosis of 
OSMF followed the pattern of salivary pooling in all patients and showed a significant 
association (p < 0.001). Isolated OSMF were associated with areas where the quid 
was placed and where the saliva pooled, which indicated that the chewing site was 
also a primary site of OSMF. Results showed that the sites where areca nut is 
chewed and saliva collects, are important factors in the distribution of OSMF. It is 
likely that the pool of saliva containing concentrated gutkha grains initiates an early 
fibrotic reaction. Furthermore, it was speculated that the patterns of pooling change 
when the mucosal surface fibroses, which would reduce the absorption of the quid, 
with the change continuing until all the oral surfaces had been affected by OSMF. It 
can therefore be inferred that OSMF develops when the preconditioned mucosa is 
faced with the challenge presented by copper through saliva pooling. 
Conclusions
The results of the thesis supported the hypotheses that: (1) Copper in drinking water 
is associated with pathogenesis of OSMF, (2) Copper in the areca nut is not the only 
cause of mucosal fibrosis, and (3) Saliva pooling is responsible for the sporadic inci-
dence of OSMF on different oral mucosal tissue. Based on the results obtained in the 
variously performed studies, the following overall conclusions can be made: 
1. OSMF is a crippling disorder that is considered to be multifactorial in origin. 
With a high incidence in people who chew areca nut, and a significant malig-
nant transformation rate (7–30%), it poses a global challenge to public health.
2. The literature review on OSMF identified the copper content of areca nut as 
the primary mediator of fibrosis because of upregulation of lysyl oxidase in 
both tissue biopsy specimens and OSMF fibroblasts
3. Most studies on OSMF have focused only on the oral copper availability and 
its local mucosal action. An equally important second aspect to consider is the 
pre-conditioning of the oral mucosa by a prolonged, chronic copper exposure 
through diet.
4. Mucosal pre-conditioning may occur due to chronic exposure to sublethal copper 
diet (food, potable water), which predisposes the oral mucosa to OSMF.
5. The association of copper in drinking water with pathogenesis of OSMF as a 
co-factor is confirmed by the results of both pilot and prospective studies.  
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6. As suggested by the results of both pilot and prospective studies, it is possible 
that raised concentrations of systemic copper caused by the regular con-
sumption of water that contains high concentrations of copper ions, plays an 
important role in the pathogenesis of OSMF. Chronic drinking or ingestion of 
copper may alter the normal threshold for the absorption of copper by the gut, 
and thereby alter the limits of metabolic tolerance to copper. When exposed to 
additional copper through the areca nut, the cumulative effect could com-
pound OSMF.
7. The data also confirmed the presence of copper-preconditioned individuals 
who had raised copper concentrations in their drinking water, serum, and sa-
liva. It can be postulated that they might have a higher risk of developing 
OSMF if they started to chew areca nut. 
8. Serum and water values of non-OSMF areca nut-chewers were within stan-
dard limits. But salivary copper concentration was found to be consistently 
higher in all individuals. The data derived from this novel investigation con-
firmed the presence of co-factors other than areca nut, which are also neces-
sary for the development of OSMF.
9. The results provided evidence that the contamination of drinking water with 
copper plays a promoting role in pathogenesis of OSMF.  This may be one 
reason why OSMF is typically found in low-socioeconomic populations who 
are exposed to contaminated water, and it also explains the high incidence of 
OSMF in developing countries, where standards and regulations for the qual-
ity of drinking water are low.
10. Salivary pooling was described as the collection of pooled saliva under pressure 
in one part of the oral cavity during the process of chewing, and that the surface 
where this occurred contained a high concentration of the gutkha ingredients. The 
prolonged exposure of the oral mucosa to saliva containing dissolved products of 
the quid, which occurs when the saliva pools in a specific area, could therefore be 
an explanation for the incidence of OSMF in multiple sites among unilateral chew-
ers, and also elucidate why some surfaces are not affected.
Future Perspectives
The results obtained in this thesis show that copper-contaminated drinking water 
plays a subtle, but crucial role in the pathogenesis of OSMF. A very important lesson 
derived from these studies was that the diseases were commonly observed among 
population with low socioeconomic status, who are prone to consume contaminated 
water. It is therefore likely that additional contaminants in drinking water may also be 
causing or promoting fibrosis of oral mucosa. 
Drinking water is derived from two basic sources: surface waters, such as rivers and 
reservoirs, and groundwater. All water contains natural contaminants, particularly 
inorganic contaminants that arise from the geological strata through which the water 
flows and, to a varying extent, anthropogenic pollution by both microorganisms and 
chemicals. In general, groundwater is less vulnerable to pollution than surface wa-
ters. Also, the natural impurities in rainwater, which replenishes groundwater sys-
tems, are removed while infiltrating through soil strata. But, in developing countries 
like India, where groundwater is used intensively for irrigation and industrial pur-
poses, a variety of land and water-based human activities are causing the pollution 
of this precious resource. Pollution of groundwater due to industrial effluents and 
municipal waste in water bodies is another major concern in many cities and indus-
trial clusters in India. Consequently, through relative industrialization and urbaniza-
tion, the water pollution of heavy metals has become an issue of concern, especially 
in view of their toxicity to human and other biological systems. Drinking water may 
for example be contaminated with copper from water pipes and plumbing fixtures, 
especially when the ph level of the water is below 7. Copper salts are sometimes 
purposely added in small amounts to water supply reservoirs in order to suppress 
the growth of algae. Organic and inorganic compounds of copper have also been 
used extensively in agricultural pesticides sprays. The element is therefore likely to 
be more readily available for solution in surface and ground water than its low aver-
age abundance in rocks might have implied. The lower concentrations of copper are 
readily explainable as a result of co-precipitation by oxides or absorption on mineral 
surfaces. It follows that, much more research is needed to assess the possible role 
of various other contaminants (e.g. fluoride) found in drinking water for OSMF. 
The studies in this thesis assessed a population in north-east Karnataka, and further 
research is needed to confirm the present findings in various other parts of the coun-
try, and also elsewhere on the South Asian (sub-) continent. Hence comparative 
studies between different states within one country, and between different countries 
should be considered.    
Another aspect requiring improvement is the standardization of the drinking water 
source in regards to the investigation of copper ion concentrations. In this study, one 
of the authors collected and refrigerated samples of drinking water (most came from 
bore holes and wells) from each patient’s home. The method was adapted to assess 
the water source at the primary level and included individuals who had lived and 
worked in the same area since birth. Those who spent time away from home (includ-
ing long-distance drivers because they did not use their regular water supply at 
home) were excluded. As a follow-up step to this research, it is suggested to assess 
the copper concentration of drinking water at various levels of the community supply, 
and test its association with regional epidemiological data of OSMF. 
This study points to the possibility of copper also influencing dietary sources other 
than water in terms of disease incidence and progression. A critical laboratory analy-
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sis of all regional dietary sources for copper concentrations (eg. food, tea, coffee etc) 
is recommended.  
For the first time, the studies undertaken as part of this thesis evaluated serum and sali-
vary copper concentrations in people who chew gutkha, but do not have OSMF; these 
are likely to be the best controls in research into this condition. They had normal serum 
values, and the copper concentration of their drinking water was within normal limits. 
However, concentrations of salivary copper were persistently higher than normal, which 
indicates that the copper content of gutkha is not the only cause of oral mucosal fibrosis. 
Further clinical and laboratory studies of non-OSMF areca-chewers and their tissues are 
required, including comparisons with OSMF patients and healthy individuals. All labora-
tory parameters should be studied in non-OSMF areca-chewers and their near relatives, 
as well as members of the same ethnic group.
The results of the thesis supported the concept of mucosal preconditioning in patho-
genesis of OSMF. It is surmised that the effect of areca nut on the oral mucosa may 
be secondary to the initial preconditioning of oral tissue. Chronic exposure to sub-
lethal concentrations of copper in drinking water might alter the normal threshold for 
its gut absorption, and might precondition the oral tissues with systemic copper ex-
posure. This may change the cellular resistance to copper, and when exposed to the 
additional copper present in the areca nut, the cumulative effect could compound the 
condition.  This is an important finding of this study in the context of prevention and 
treatment of OSMF. The disease incidence can be controlled effectively by prevent-
ing preconditioning of oral tissue, which necessitates measures to prevent and cure 
groundwater quality deterioration. This may also effectively prevent recurrence or 
disease progression after treatment, which may be because of persistent precondi-
tioning of oral tissues. Hence, a well-designed animal experiment to demonstrate 
preconditioning of oral mucosa with copper in drinking water is recommended.  
Treatment follow-up studies of OSMF that observe the possibility of recurrence or 
progression, and concomitant monitoring of copper values (in serum, saliva and 
drinking water) are recommended to demonstrate the role of persistent copper pre-
conditioning in treatment failure.   
The potential for the development of squamous cell carcinoma among OSMF pa-
tients should also be further studied through investigations of drinking water, serum 
and saliva copper concentration. It is apparent that in many cases of oral carcinoma, 
the serum level of copper is found to be elevated, which may be correlated to the 
copper concentration of drinking water. In the severe stages of OSMF, trismus and 
burning sensations restrict solid food ingestion. This triggers an increased water in-
take in patients, which may exceed metabolic tolerance, alter systemic levels of cop-
per, and drive the initiation of malignant change.  
There is an obvious need for public awareness regarding water purification.  Addi-
tionally, there is a dire need for medical and dental training, as well as for the continu-
ing education of dental therapists, government dental and medical officers and den-
tal surgeons working in the developing districts and regions. This may be accomplished 
through additional instructional courses emphasizing the importance of ‘precondi-
tioning and drinking water’ in preventing and treating OSMF.     
Finally, to reduce the incidence of OSMF, high drinking water standards must be 
maintained. Stringent preventive and curative measures are recommended against 
the pollution and contamination of groundwater.
92 93
Chapter 8
Samenvatting en conclusies en Perspectieven  
voor de toekomst
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Samenvatting
Deze proefschrift is gebaseerd op studies naar de rol van koperconcentraties in 
drinkwater bij de pathogenese van orale submuceuze fibrose (OSF), evenals de rol 
van verhoging van koperconcentratie in het speeksel bij de sporadische incidentie 
van OSF in de orale mucosa (mondslijmvlies). Het onderzoek is uitgevoerd in het 
noordoosten van Karnataka, een regio in India, met de steun van subsidies van de 
British Association of Oral and Maxillofacial Surgery (BAOMS, Britse vereniging voor 
mond- en kaak- en aangezichtschirurgie), Londen, Verenigd Koninkrijk, onder leiding 
van professor Matthias A.W. Merkx van de Radboud Universiteit Nijmegen (Neder-
land) en professor Peter A. Brennan van de University of Portsmouth (Verenigd 
Koninkrijk). De vooronderstelling van het onderzoekswerk is gebaseerd op het feit 
dat OSF enkel voorkomt bij een klein aantal betelnoot kauwers en verder slechts 
een sporadische incidentie vertoont, ongeacht het kauwgebied in de mondholte. De 
hypothese was dat verhoogde systemische koperconcentraties een belangrijke rol 
speelden bij de pathogenese van OSF. Dit kwam door het regelmatig drinken van 
water met hoge concentraties koperionen. Ook werd gesteld dat het patroon van 
koperstapeling in het speeksel vaak de locatie spreiding van OSF beïnvloedt.
De onderzoeksdoelen waren:
• De bestaande literatuur over OSF evalueren en de diverse aspecten van de 
aandoening bespreken. 
• Hypothesen bespreken voor de mogelijke mechanismen van de ontwikkel-
ing van OSF door koper in de voeding.
• De mogelijke rol van koper in drinkwater bespreken bij de pathogenese van 
OSF aan de hand van een pilot-onderzoek. 
• De relatie van koper in het drinkwater en OSF beoordelen met een prospec-
tief patiëntcontrole-onderzoek.
• Koperstapeling in het speeksel onderzoeken als bijdragende factor bij de 
pathogenese van OSF, en de rol ervan beoordelen bij het distributiepatroon 
van de ziekte.
In Hoofdstuk 1 wordt de rationale van het onderzoek gepresenteerd. Orale submu-
ceuze fibrose (OSF) is een ernstige aandoening in de mondholte. Het veroorzaakt 
een progressieve littekenvorming van de orale mucosa. Dit leidt tot een progressieve 
beperking van de mondopening. Uiteindelijk krijgen de patiënten functionele proble-
men met eten en slikken. Dit heeft een sterk nadelige invloed op de voedingsstatus 
van het lichaam. Naarmate de ziekte voortschrijdt, kunnen er spraak- en gehoor-
problemen en een gebrekkige smaakzin ontstaan. Het bindweefsel in de pharynxbo-
gen varieert van een licht submuceuze verlitteking in beide bogen, tot een dichte fi-
brose die zich uitstrekt tot diep in beide bogen en de tonsillen beknelt. Deze dichte 
fibrose van het weefsel rond de raphe pterygomandibularis veroorzaakt problemen 
in diverse gradaties bij het openen van de mond. Tot voor kort werd gedacht dat het 
een lokaal probleem was en alleen op het Indische subcontinent, China en andere 
regio’s in Zuidoost-Azië voorkwam. Door de grote aantallen migranten die deze aan-
doening ook hebben, wordt het nu echter gezien als een wereldwijd probleem. De 
incidentie van OSF stijgt onder de jongeren in India, en verspreidt zich geruisloos en 
razendsnel door heel India. Het wordt gezien als een premaligne stadium van mond-
kanker, en er is een significant risico te zien van maligne transformatie (7,6%).
Hoewel er zes decennia voorbij zijn gegaan nadat de aandoening voor het eerst 
werd aangetoond, is er nog steeds geen duidelijke remedie gevonden die zich on-
omstotelijk als zodanig heeft bewezen. Ondanks het niet-aflatende onderzoek bli-
jven er controverses bestaan wat betreft de pathogenese en bepaalde aspecten van 
de bestaande behandelmethoden die nog steeds twijfelachtig zijn. Dit kan komen 
doordat de aandoening complex en de oorsprong multifactorieel is. Bestaande 
onderzoeksgegevens kunnen slechts enkele aspecten verklaren van de veelzijdige 
aandoening, en er kunnen andere factoren meespelen die over het hoofd zijn gezien 
en nog moeten worden opgehelderd. 
OSF is zonder twijfel een invaliderende ziekte. Het is niet levensbedreigend, maar 
het vormt een grote bedreiging op de lange termijn omdat een groot deel van de 
bevolking mondkanker kan krijgen. 
Als gevolg van bovenstaande overwegingen zijn de volgende onderzoeksvragen 
geformuleerd: 
• Waarom is er vaak een progressie van OSF, zelfs nadat is gestopt met het 
kauwen op betelnoten?
• Waarom recidiveert de OSF, zelfs na een medische behandeling en zonder 
dat er nog wordt gekauwd op betelnoten?
• Waarom komt de aandoening OSF zo vaak voor in de lagere sociaalecono-
mische lagen van de bevolking, en is deze in geografisch opzicht verspreid 
in de gordel van ontwikkelingslanden? 
• Hoe groot is de kans dat koper in de betelnoten een rol speelt bij de patho-
genese van OSF?
• Als koper in de betelnoot de hoofdoorzaak is van OSF, waarom zijn dan niet 
alle betelnoot kauwers getroffen door de aandoening? 
• Is er een mogelijkheid op blootstelling aan koper van de orale mucosa via de 
systemische route? 
• Waarom krijgen sommige mensen al in een vroeg stadium OSF als ze be-
ginnen met het kauwen op betelnoten?
• Wat is de reden van de incidentie van OSF op meerdere plekken bij eenzij-
dige betelnoot kauwers? 
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Hoofdstuk 2 evalueert de huidige literatuur over OSF. Hierin worden alle compo-
nenten van OSF geëvalueerd en besproken, inclusief de terminologie, presentatie, 
etiologie en pathogenese. Ook geeft het hoofdstuk een kort overzicht van de behan-
deling. OSF is beschreven sinds 1952. Het zou multifactorieel zijn met een hoge 
incidentie onder mensen die kauwen op betelnoten, en het significante percentage 
van maligne transformatie (7–30%) vormt wereldwijd problemen voor de volksge-
zondheid. Het werd vroeger beperkt tot het Indische subcontinent, maar het komt nu 
ook vaak voor onder de Aziatische bevolkingsgroepen in het Verenigd Koninkrijk, de 
Verenigde Staten en andere westerse landen. Het is daarom wereldwijd een serieus 
probleem voor de volksgezondheid. Er zijn overtuigende bewijzen dat de betelnoot 
een belangrijke rol speelt bij de ontwikkeling van OSF. Diverse patiënt controle-
onderzoeken hebben overtuigende bewijzen geleverd dat er zeker een dosisafhan-
kelijke relatie is tussen het kauwen van betelnoten en het ontstaan van de ziekte. De 
aanvang van de ziekte is direct evenredig met de concentratie, incidentie en duur 
van het kauwen op deze noot. De hoge concentratie van koper in betelnoten stimu-
leert de werking van lysyl oxidase, een enzym dat essentieel is voor de uiteindelijke 
crosslinking van collageen vezels. Er is een verhoogd gehalte aan koper aangetrof-
fen in slijmvliezen die zijn aangetast door OSF. Dit ondersteunt de rol van fibrogen-
ese bij het vergroten van de activiteit van lysyl oxidase. Wat de basis ook is, een 
verstoring van het evenwicht in de extracellulaire matrix en de voortdurende depositie 
van extracellulaire matrix bij OSF zijn momenteel algemeen geaccepteerd. Het lijkt erop 
dat de veranderingen die optreden in de extracellulaire matrix waarschijnlijk een sleutel-
rol spelen. Desondanks blijft het raadsel rond orale submuceuze fibrose (OSF) nog 
steeds bestaan. Ondanks onderzoeken die al meer dan drie decennia omvatten, is de 
pathogenese nog steeds niet volledig doorgrond. We moeten nu verstandig investeren 
in het onderzoek, zodat we de diverse factoren exact kunnen identificeren die bijdragen 
aan het ontstaan van OSF of de ontwikkeling ervan stimuleren, en die ook van invloed 
zijn op de ziekteprogressie en de behandelresultaten. 
Hoofdstuk 3 geeft een hypothese om de preconditionering van de orale mucosa uit 
te leggen, welke een belangrijke rol kan spelen bij de pathogenese van OSF. Di-
verse hypothesen die tot nu toe naar voren zijn gebracht om de pathogenese van 
OSF op te helderen, zijn nog niet als zodanig bewezen. De exacte rol van koper bij 
de pathogenese van fibrose blijft nog steeds onduidelijk. De meeste onderzoeken 
naar OSF hebben alleen nadruk gelegd op de orale beschikbaarheid van koper en 
de lokale inwerking op de slijmvliezen. Een tweede aspect dat net zo belangrijk is en 
ook moet worden bekeken, is de preconditionering van de orale mucosa door een 
langdurige, chronische blootstelling aan koper. Resultaten van bestaande studies in 
de literatuur roepen de vraag op waarom er vaak een ziekteprogressie is, zelfs nadat 
de gewoonte om op betelnoten te kauwen is gestaakt, en waarom er recidieven zijn 
zelfs na een medische behandeling en er niet meer op betelnoten wordt gekauwd. 
In het huidige onderzoek wordt gesteld dat de chronische blootstelling aan de in-
name van een sublethale koperconcentratie (via voeding, koper in drinkwater) de 
orale mucosa gevoelig maakt voor OSF. Dit werd verklaard aan de hand van twee 
overlappende paden, namelijk wijziging van de koperconcentraties in speeksel door 
een verhoogde secretie en de preconditionering van de orale mucosa via chronische 
blootstelling aan koper vanuit het speeksel. Muceuze fibrose kan beginnen als de 
gepreconditioneerde orale mucosa extra wordt blootgesteld aan koper bij het kauw-
en op betelnoten. De aanwezigheid van aanvullende factoren (systemische factoren 
of andere lokale factoren zoals voedsel met chilipepers) kunnen het ontstaan en de 
ernst bepalen. Zodra de afwijking aanwezig is, is er sprake van hypoperfusie van de 
weefsels door fibrose. De klaring van koper uit het weefsel kan vervolgens verder 
worden vertraagd. Hierdoor nemen de koperconcentraties in het weefsel toe, waar-
door de fibrose verergert. De aandoening komt in een vicieuze cirkel terecht. De 
mondopening wordt steeds verder beperkt, waardoor de patiënt vatbaar wordt voor 
geestelijke en lichamelijke stress en verdere fibrosering. Om de hypothese te testen, 
wordt een zorgvuldig onderzoek naar de koperconcentraties in drinkwater (binnen 
de gemeenschap en thuis) en in het voedsel aangeraden. De concentraties kunnen 
samenhangen met het kopergehalte in het serum en het speeksel. Bovendien kan 
ceruloplasmine in het serum de systemische predispositie valideren.
Hoofdstuk 4 beschrijft een pilot-onderzoek om te bepalen of koper in het drinkwater 
een rol speelt bij de pathogenese van OSF. De onderzoeksgroep voor de pilot be-
stond uit 100 mensen uit het Yadgir-district in Karnataka, India. Aan het pilot-onder-
zoek namen 50 patiënten deel die klinisch en histologisch waren gediagnosticeerd 
met OSF. Zij vormden de onderzoeksgroep. Voor de controlegroep werden er 50 
gezonde mensen gerekruteerd die qua leeftijd en geslacht overeenkwamen met de 
onderzoeksgroep. Beide groepen werden onderzocht op koperconcentraties in het 
serum en het speeksel. De koperionenconcentratie in drinkwater werd gemeten via 
atomaire absorptiespectrometrie en intelligente nefelometrie. De gemiddelde koper-
concentratie in het drinkwater thuis bij de patiënten met OSF was significant hoger 
(764,3 ± 445,9 µmol/l) dan bij de controlegroep (305,7 ± 318,5 µmol/l) (p < 0,001). 
Patiënten met OSF hadden ook een aanzienlijk hogere koperconcentratie in hun 
serum en speeksel, en ceruloplasmine in het serum dan de controlegroep (p < 
0,001). De gegevens toonden een positief verband van koper in het drinkwater en 
OSF. Het kan dus zijn dat een hoognormaal kopergehalte in het drinkwater bijdraagt 
aan de ontwikkeling van OSF, bovenop het koper dat vrij komt bij het kauwen op 
betelnoten. Opmerkelijk genoeg hadden acht vrijwilligers (16%) in de controlegroep 
verhoogde koperconcentraties in hun drinkwater, serum en speeksel. Gesteld werd 
dat ze misschien een hoger risico hadden om OSF te krijgen als ze op betelnoten 
zouden gaan kauwen, maar verder onderzoek werd aanbevolen om het verband te 
begrijpen binnen een grote heterogene groep en om er zeker van te zijn dat de ho-
eveelheid water die is gedronken proportioneel is aan de totale koperconcentratie in 
serum, of dat de rol ervan kleiner is dan de rol van koper in betelnoten. 
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Hoofdstuk 5 beschrijft een prospectief patiëntcontrole-onderzoek, uitgevoerd als 
reactie op de significante resultaten van het pilot-onderzoek waarin bewijzen zijn 
gegeven dat koperionen in drinkwater een rol spelen bij de pathogenese van OSF. 
Het verband werd nader onderzocht in een grote, heterogene populatie uit de regio 
Hyderabad-Karnataka (bestaande uit 6 districten) in Karnataka, India. Bij het onder-
zoek werden 3 groepen bestudeerd, elk van 100 patiënten: degenen met OSF die 
gutka kauwden, degenen die gutka kauwen maar geen OSF hadden, en gezonde 
controlepersonen die geen gutka kauwden. Alle drie de groepen werden onderwor-
pen aan onderzoeken op koperconcentraties in het serum, speeksel en het drinkwa-
ter. Dit was het eerste onderzoek naar de koperconcentraties in het serum en speek-
sel van mensen die gutka kauwden maar geen OSF hadden. Zij zijn waarschijnlijk 
de beste controlepersonen bij het onderzoek naar deze aandoening. De gemiddelde 
koperconcentratie in het water was hoger (388,53 ±229,23 µmol/l) in de OSF-groep 
dan in de twee andere groepen. De concentraties van koper in het drinkwater waren 
het laagst in de groep zonder OSF (203,82± 82,80 µmol/l). Significante verschillen 
tussen de groepen werden ook aangetroffen in de gemiddelde concentraties van 
koper in het serum en in het speeksel, en het gehalte aan ceruloplasmine (p < 0,001). 
Concentraties van serumkoper en het ceruloplasmine waren hoger dan normaal in 
de OSF-groep (respectievelijk 37% en 35%) en de controlegroep (respectievelijk 
19% en 17%). Alle kauwers op betelnoten zonder OSF hadden waarden binnen de 
standaardlimieten voor het serum ceruloplasmine en voor concentraties van koper 
in het serum en het water, maar ze hadden allemaal hogere koperconcentraties dan 
normaal in het speeksel (n=100). Er was een positieve correlatie tussen de koper-
concentraties in het water, serum en speeksel in de OSF-groep en de controlegroep. 
Het onderzoek dat werd uitgevoerd onder een grotere groep van 300 patiënten bev-
estigde het significante verband tussen OSF en koper in drinkwater. Dit ondersteunt 
het idee van ‘muceuze preconditionering’. Een chronische blootstelling aan hoog-
normale concentraties van koper in drinkwater kan de normale drempel voor de 
absorptie aanpassen, de cellulaire weerstand voor koper wijzigen en de orale mu-
cosa vatbaar maken voor OSF. Bij een blootstelling aan extra koper in de betelnoot 
zou het cumulatieve effect de ziekte kunnen verergeren. Ook werd ontdekt dat de 
concentraties van koper in het speeksel hoger waren dan normaal in beide groepen 
die gutka kauwden (85% van de OSF-groep en iedereen in de groep zonder OSF). 
Dit suggereert dat koper uit gutka of betelnoten zich constant in het speeksel stapelt, 
maar dat de orale mucosa anders reageert. Het kan ook zijn dat de orale mucosa bij 
patiënten met OSF is gepreconditioneerd door chronisch verhoogde koperconcen-
traties in water, of dat er een drempel nodig is voor het totale kopergehalte om de 
aandoening te triggeren. In zijn geheel toonde deze omvangrijke studie een posi-
tieve correlatie aan tussen de incidentie van OSF en de concentraties van koper in 
drinkwater. Het gaf ook een aanwijzing dat lokaal beschikbaar koper in speeksel niet 
de enige oorzaak is van OSF, maar wel gevoelig gemaakte slijmvliezen kan aantas-
ten. Dit kan verklaren waarom sommige mensen die constant kauwen op gutka of 
betelnoten de ziekte niet krijgen.
Hoofdstuk 6 beschrijft een onderzoek met het doel om de rol van speekselophoping 
te beoordelen in een sporadisch distributiepatroon van OSF in de mondholte. De 
onderzoeken uit eerdere hoofdstukken gaven genoeg gegevens over muceuze pre-
conditionering en de kwetsbaarheid voor OSF bij blootstelling aan het kauwen op 
betelnoten. Het fenomeen van preconditionering was echter minder nuttig bij het 
verklaren van de incidentie van OSF op meerdere plekken onder mensen die unilat-
eraal kauwden, en waarom sommige gebieden niet zijn aangetast. Het onderzoek 
was dus bedoeld om de reden te verklaren voor de gevarieerde distributie van OSF. 
Gesteld werd dat een voortdurende blootstelling van de orale mucosa aan speeksel 
met opgeloste stoffen uit het gutka pruimtabak fibrose kan veroorzaken. Dit treedt op 
wanneer het speeksel zich ophoopt in een bepaald gebied. Veronderstelt kan dan 
ook worden dat het patroon van ophoping de distributie van OSF beïnvloedt. Het 
onderzoek omvatte 174 patiënten met OSF uit het Yadgir-district in Hyderabad–Kar-
nataka, India. Elke patiënt (die 5 minuten lang de gutka in zijn mond hield) kreeg de 
6 plaatsen in de mondholte te zien van een gezonde proefpersoon, en de vraag 
waar ze het pruimtabak hielden en welke vlakken zijn aangetast door speekselo-
phoping. Deze werden vastgelegd door één van de auteurs. Een panel van 3 onder-
zoekers (medisch team) onderzocht de patiënten herhaaldelijk om de mondholte te 
beoordelen. De plaatsen in de mondholte waar gutka werd gekauwd en waar de 
speekselophoping was, werden vastgelegd om te zien of ze een verband hadden 
met de locaties van OSF. De klinische diagnose van OSF volgde het patroon van de 
speekselophoping bij alle patiënten, en toonde een significant verband (p < 0,001). 
Geïsoleerde OSF werd in verband gebracht met gebieden waar het pruimtabak was 
geplaatst, en waar het speeksel zich ophoopte. Dit toonde aan dat de kauwplaats de 
belangrijkste locatie was van het ontstaan van OSF. De resultaten toonden aan dat 
de plekken waar betelnoten werden gekauwd en speeksel zich ophoopt belangrijke 
factoren zijn bij de distributie van OSF. Waarschijnlijk veroorzaakt de ophoping van 
speeksel met geconcentreerde gutka-korrels een vroege reactie van fibrose. Verder 
werd gespeculeerd dat het patroon van ophoping verandert bij fibrose van het slijm-
vliesoppervlak, waardoor er minder stoffen uit het pruimtabak wordt geabsorbeerd. 
De veranderingen gaan door tot alle orale vlakken zijn aangetast door OSF. Gecon-
cludeerd kan worden dat OSF zich ontwikkelt wanneer gepreconditioneerde slijmv-
liezen een extra koperblootstelling krijgen via speekselophoping. 
Conclusies
De resultaten van de scriptie ondersteunen de hypothesen dat: (1) koper in het 
drinkwater verband houdt met de pathogenese van OSF, (2) koper in de betelnoot 
niet de enige oorzaak is van muceuze fibrose en (3) speekselophoping verant-
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woordelijk is voor de sporadische incidentie van OSF op verschillende orale mu-
ceuze weefsels. Op basis van de verkregen resultaten uit de uitgevoerde onder-
zoeken, kunnen de volgende algemene conclusies worden getrokken: 
1. OSF is een invaliderende ziekte met een multifactoriële oorsprong en een 
hoge incidentie onder mensen die op betelnoten kauwen. Een significante 
maligne transformatie (7–30%) veroorzaakt wereldwijd problemen voor de 
volksgezondheid.
2. Het literatuuronderzoek naar OSF identificeert het kopergehalte van de 
betelnoot als primaire mediator van fibrose vanwege de opregulatie van lysyl 
oxidase in weefselbiopten en OSF-fibroblasten.
3. De meeste onderzoeken naar OSF hebben alleen nadruk gelegd op de orale 
koperbeschikbaarheid en de lokale inwerking op de slijmvliezen. Een even 
belangrijk tweede aspect dat moet worden beschouwd, is de preconditioner-
ing van orale slijmvliezen door een langdurige, chronische blootstelling aan 
koper via de voeding.
4. Muceuze preconditionering kan optreden door een chronische blootstelling 
aan een sublethale koperconcentratie in het eetpatroon (voeding en drinkwa-
ter) die de orale mucosa predisponeert voor OSF.
5. De relatie van koper in het drinkwater met de pathogenese van OSF als co-
factor is bevestigd aan de hand van de resultaten van de pilot-onderzoeken 
en prospectieve onderzoeken.
6. Zoals gesuggereerd aan de hand van de resultaten van de pilot-onderzoeken 
en prospectieve onderzoeken is het mogelijk dat een verhoogde concentratie 
van systemisch koper, veroorzaakt door het regelmatig drinken van drinkwa-
ter met hoge concentraties koperionen, een belangrijke rol speelt bij de patho-
genese van OSF. Het chronisch drinken of innemen van koper kan de nor-
male drempel veranderen voor de absorptie van koper door de darmen, en de 
grenzen veranderen van de metabole tolerantie voor koper. Bij blootstelling 
aan extra koper in de betelnoot kan het cumulatieve effect bijdragen aan OSF.
7. De gegevens bevestigden ook de aanwezigheid van door koper geprecondi-
tioneerde personen die verhoogde koperconcentraties in hun drinkwater, se-
rum en speeksel hadden. Gesteld kan worden dat ze een hoger risico hebben 
om OSF te krijgen als ze gaan kauwen op betelnoten. 
8. De koperconcentratie in serum en water onder betelnoot kauwers zonder 
OSF waren binnen de standaardlimieten. Maar de koperconcentratie in het 
speeksel was bij alle personen consequent hoger. Gegevens van dit nieuwe 
onderzoek bevestigden de aanwezigheid van cofactoren naast de betelnoten 
die nodig zijn voor de ontwikkeling van OSF.
9. De resultaten bewijzen dat de watervervuiling met koper de pathogenese van 
OSF mede kan bevorderen. Dit kan een reden zijn waarom OSF vooral 
voorkomt in de lagere sociaaleconomische klassen, die vaker blootgesteld 
worden aan vervuild water. Tevens verklaart het de hoge incidentie van OSF 
in ontwikkelingslanden, waar de normen en richtlijnen voor de kwaliteit van 
drinkwater niet streng zijn.
10. Speekselophoping wordt omschreven als een verzameling van opgehoopt 
speeksel onder druk in een bepaald deel van de mondholte tijdens het kauw-
proces. Het oppervlak van die plaats bevatte een hoge concentratie van de 
gutka-ingrediënten. De langdurige blootstelling van de orale mucosa aan 
speeksel met opgeloste producten van het pruimtabak (dit gebeurt wanneer 
het speeksel zich ophoopt in een bepaald gebied) kan een uitleg zijn voor de 
incidentie van OSF op meerdere plekken onder unilaterale pruimtabak kauw-
ers en ook waarom sommige oppervlakten niet zijn aangetast.
Perspectieven voor de toekomst
Resultaten van dit onderzoek hebben aangetoond dat drinkwater vervuild met koper 
een subtiele maar cruciale rol speelt bij de pathogenese van OSF. Een erg belangri-
jke les is dat de aandoeningen vaak voorkomen onder populaties uit lagere so-
ciaaleconomische klassen, omdat deze vaker vervuild water consumeren. Het is 
waarschijnlijk dat er nog andere vervuilende stoffen in het drinkwater fibrose van de 
orale mucosa veroorzaken of de ontwikkeling ervan stimuleren. 
Drinkwater komt uit twee basisbronnen: oppervlaktewater, zoals rivieren en bassins, 
en grondwater. Al het water bevat natuurlijke vervuilende stoffen, vooral anor-
ganische vervuilende stoffen uit de geologische lagen waardoor het water stroomt, 
en in variabele mate antropogene vervuiling door micro-organismen en chemicaliën. 
Over het algemeen is grondwater minder kwetsbaar voor vervuiling dan opperv-
laktewater. De onzuiverheden in regenwater dat het grondwater aanvult, worden 
bovendien verwijderd als het door de bodemlagen sijpelt. Maar in ontwikkeling-
slanden zoals India, waar grondwater intensief wordt gebruikt voor de irrigatie en 
industriële doeleinden, veroorzaken diverse land- en wateractiviteiten van de mens 
vervuiling van deze kostbare hulpbron. Vervuiling van het grondwater door indus-
trieel en stedelijk afvalwater in waterbassins is een andere belangrijke bron van zorg 
in veel steden en industriegebieden in India. Bij een relatieve industrialisatie en ur-
banisatie is de vervuiling van water met zware metalen daarom een bron van zorg 
geworden, vanwege de toxiciteit van die stoffen voor mensen en andere biologische 
systemen. Drinkwater kan vervuild zijn met koper uit de waterleidingen en riolerin-
gen, vooral bij een pH-waarde lager dan 7. Koperzouten worden soms expres in 
kleine hoeveelheden toegevoegd aan kleine waterbassins om de groei van algen 
tegen te gaan. Organische en anorganische verbindingen van koper worden daar-
naast extensief gebruikt in spuitbussen met landbouwpesticiden. Koper is daarom 
waarschijnlijk meer beschikbaar voor de oplossing in het oppervlaktewater en grond-
water dan het lage gemiddelde gehalte in rotsen zou doen vermoeden. De lagere 
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concentraties van koper zijn gemakkelijker te verklaren als gevolg van coprecipitatie 
door oxiden en de absorptie op minerale oppervlakken. Daarom moet er veel meer 
onderzoek worden gedaan om de mogelijke rol van diverse andere vervuilende stof-
fen (bijv. fluoride) in drinkwater op OSF te onderzoeken. 
De onderzoeken in deze studie zijn gehouden onder de bevolkingsgroep in het noor-
doosten van Karnataka en nadere onderzoeken moeten deze bevindingen bevesti-
gen voor andere delen in het land en het Zuid-Aziatische continent. Dan kan er een 
vergelijking worden overwogen van de onderzoeken binnen het land zelf en tussen 
verschillende landen.
Een ander aspect dat verbetering behoeft, is dat drinkwater standaard wordt onder-
zocht op de concentratie van koperionen. In dit onderzoek heeft een van de auteurs 
monsters van drinkwater verzameld en gekoeld bewaard (de meeste monsters kwa-
men uit putten en bronnen) uit de huizen van de patiënten. De methode was aange-
past om de waterbron op primair niveau te onderzoeken, en er namen personen 
deel die al sinds hun geboorte in dat gebied woonden en werkten. Mensen die een 
tijd van huis waren geweest, werden uitgesloten (zoals chauffeurs voor lange afstan-
den, omdat ze niet hun gebruikelijke waterbron thuis hadden gebruikt). Als verdere 
stap in dit onderzoek wordt geadviseerd om de koperconcentraties in drinkwater te 
onderzoeken op diverse niveaus van de gemeentelijke watervoorziening, en het ver-
band met regionale epidemiologische gegevens van OSF te testen. 
Dit onderzoek wijst op de mogelijke invloed van koper uit een andere voedingsbron 
(anders dan water) op de incidentie en progressie van de ziekte. Een kritisch labo-
ratoriumonderzoek van alle regionale voedingsbronnen voor koperconcentraties 
(bijv. voeding, thee, koffie, enz.) wordt aanbevolen.
Voor het eerst wordt in deze studie onderzoek gedaan naar de koperconcentratie in het 
serum en speeksel van mensen die gutka kauwden, maar geen OSF hadden. Zij zijn 
waarschijnlijk de beste controlepersonen voor het onderzoek naar deze aandoening. Ze 
hadden normale serumwaarden, en het kopergehalte in het drinkwater viel binnen de 
normale waarden. Echter, de concentraties van koper in het speeksel waren consequent 
hoger dan normaal, wat erop duidt dat het kopergehalte van gutka niet de enige oorzaak 
is van orale muceuze fibrose. Verdere klinische onderzoeken en laboratoriumonder-
zoeken van betelnoot kauwers zonder OSF en hun weefsels zijn nodig, inclusief een 
vergelijking met OSF-patiënten en gezonde mensen. Alle laboratoriumparameters 
moeten worden onderzocht bij betelnoot kauwers zonder OSF en hun naaste fami-
lieleden, evenals leden uit dezelfde etnische groep.
De resultaten van deze studie ondersteunen het concept van muceuze precondi-
tionering in de pathogenese van OSF. De interpretatie hiervan is dat het effect van 
betelnoten op de orale mucosa secundair kan zijn aan de eerdere preconditionering 
van het orale weefsel. Een chronische blootstelling aan sublethale koperconcentra-
ties in drinkwater kan de normale drempel voor de absorptie in de darmen wijzigen, 
en de orale weefsels kunnen worden gepreconditioneerd door de systemische ko-
perblootstelling. Dit kan de cellulaire weerstand tegen koper veranderen en bij bloot-
stelling aan extra koper in de betelnoot kan het cumulatieve effect bijdragen aan het 
ontstaan van de aandoening. Dit is een belangrijke bevinding van het onderzoek wat 
betreft de preventie en behandeling van OSF. De incidentie van de ziekte kan effec-
tief worden gecontroleerd door preconditionering van de orale weefsels te voorkomen. 
Hiervoor zijn er maatregelen nodig om een verslechtering van de grondwaterkwalit-
eit te voorkomen en de kwaliteit juist te verbeteren. Dit kan ook recidieven of een 
progressie effectief voorkomen na een behandeling, die mogelijk door een aanhou-
dende preconditionering van orale weefsels worden veroorzaakt. Daarom is het aan 
te raden om de preconditionering van orale slijmvliezen door koper in drinkwater te 
onderzoeken met goed opgezette dierproeven. 
Vervolgonderzoeken met behandeling van OSF waarbij wordt gekeken naar de mo-
gelijkheid van recidieven of progressie en bijkomende bewaking van koperwaarden 
(in serum, speeksel en drinkwater) zijn aanbevolen om de rol van aanhoudende 
preconditionering door koper aan te tonen bij het falen van de behandeling.
De mogelijke ontwikkeling van een mondholte carcinoom onder patiënten met OSF 
moet verder worden onderzocht door de koperconcentraties in het drinkwater, se-
rum en speeksel te meten. Het is duidelijk dat in veel gevallen van orale carcinomen 
het kopergehalte in het serum is verhoogd, wat verband kan houden met de koper-
concentratie in het drinkwater. Bij ernstige gevallen van OSF kan door trismus en 
een brandend pijnsensatie de inname van vast voedsel beperkt zijn. Hierdoor zal de 
patiënt meer water drinken, waardoor de metabole tolerantie misschien wordt over-
schreden, de systemische gehalten van koper worden veranderd en het ontstaan 
van maligne veranderingen wordt beïnvloed.
Het is duidelijk nodig de overheid bewust te maken van de noodzaak van waterzuiv-
ering. Ook moeten er medische en tandheelkundige opleidingen komen en moeten 
er meer mondhygiënisten, (tand)artsen in overheidsdienst worden opgeleid, die in 
onderontwikkelde districten en regio’s aan het werk gaan. Met onderwijs gericht op 
het belang van ‘preconditionering en drinkwater’, kan OSF mogelijk beter voorkomen 
en behandeld worden. 
Tot slot moet de kwaliteitseisen van het drinkwater hoog blijven om de incidentie van 
OSF te verminderen. Strikte preventieve en curatieve maatregelen worden aanbev-
olen tegen vervuiling en verontreiniging van het drinkwater. 
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